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ABSTRACT
THE FUNCTION OF PAB1 IN TRANSLATION
AND IN
PUF3 DEPENDENT DEADENYLATION
by
Darren J. Lee
University of New Hampshire, December 2007
The involvement of the poly(A)-binding protein (PAB1) in deadenylation and
translation is well known. How PAB1 inhibits deadenylation and promotes translation is
not well understood. I have analyzed PAB1 variants, containing entire domain deletions
and substitutions of yeast residues with human residues. Chapter I discusses and
provides in vivo translation rates of strains containing PAB1 variants, defects in mRNA
degradation proteins, and defects in translation components. In chapter II, I address the
role of PAB1 in regulated deadenylation. For this analysis I studied the effect of PUF3, a
member of the PUF family of proteins that bind specific 3 ’ UTR sequences and
accelerate deadenylation and/or repress translation of the target transcript.
The analysis of in vivo translation rates, showed that while PAB1 did not have a
major role in translation, its RRM1 and RRM2 domains were the most important for
translation. I found defects in translation initiation factors, eIF4E and eIF3, had different
effects on translation in combination with two PAB1 variants in the RRM2 domain that
affect different aspects of translation in vitro. CAF1 and CCR4, two components of the
CCR4-NOT complex responsible for deadenylation, have recently been shown to have
separate functions in deadenylation. It has been suggested CAF1 and CCR4 have roles in
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translation. I show CAF1 and CCR4 do in fact have roles in translation, but as with
deadenylation, those roles in translation are different.
The mechanism for PUF mediated deadenylation has recently been shown to
involve recruitment of CCR4 via CAF1, suggesting PUF proteins accelerate
deadenylation by increasing the local concentration of deadenylases around the mRNA.
Since PUF proteins are involved in repression of translation it has been suggested that
they also accelerate deadenylation through perturbation of the mRNP complex. In this
work I show that PTJF3 requires the PAB1 RRM1 domain for deadenylation of COX17
mRNA. Additionally, I show that PUF3 bypasses the requirement of the PAB1 P domain
for deadenylation, and is required for acceleration of deadenylation through defects in the
cap binding protein, eIF4E. This suggests that PUF3 interacts with PAB1 to disturb the
mRNP complex to accelerate deadenylation of COX17 mRNA.
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GENERAL INTRODUCTION

Proper and appropriate gene expression is essential to cellular processes ranging
from following developmental cues to monitoring metabolic activity. Multiple levels of
control are utilized to obtain proper gene expression. These controls include: promoter
enhancers and suppressors to regulate transcriptional initiation, chromatin remodeling
complexes which positively and negatively regulate transcriptional elongation, mRNA
transcript stability controls the amount of protein that can be translated, various
translation initiation complexes regulate the translational process, and events such as
methylation and phosphorylation occur post-translationally to further regulation protein
function. One area of particular interest is mRNA transcript stability, specifically factors
contributing to differential transcript stability. Illustrating the wide-range of transcripts
stability is the stable mRNA transcript, PGK1, which has a 33 minute half-life (Muhlrad
et al., 1995), and the unstable mRNA transcript, MFA2, which has a 3.5 minute half-life
(Muhlrad and Parker, 1992). Since the mRNA half-life is directly related to the amount
of protein that is translated from the mRNA it is important to understand the factors
contributing to how one mRNA has a longer half-life compared to another mRNA with a
shorter half-life. Additionally, translationally competent mRNA is absolutely required
fo r the tran slatio n o f protein. It is therefore im portant to understand the factors that

control translation and the factors involved in determining mRNA degradation.
Furthermore, a link between mRNA degradation and translation initiation has been
shown (Schwartz and Parker, 1999), which indicates the need to understand the

1
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mechanisms behind both processes. In this dissertation I have focused on two areas: how
the PUF proteins act to deadenylate COX17 mRNA, and how PAB1 and components
involved in both mRNA degradation and translation affect translation.

2
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Figure 1 - Pathways of eukaryotic mRNA degradation. From Coller and Parker 2004.
Several pathways of mRNA degradation are known. The major degradation pathway
requires deadenylation of the poly(A) tail, however, other deadenylation independent
pathways exist.
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mRNA Degradation
The pathways of mRNA degradation can be grouped into two types,
deadenylation dependent and deadenylation independent (Figure 1). The deadenylation
dependent pathway is the major mRNA degradation pathway. Degradation of the mRNA
body occurs following exonucleolytic digestion of the adenines (deadenylation) at the 3’
end of the mRNA and decapping of the 5’ 7-meG cap. In yeast, the poly(A) tail is
initially trimmed by the PAN2/PAN3 complex from 100-110 A ’s to 70-90 adenines (A’s)
(Tucker et al., 2002). The remaining poly(A) tail is digested to approximately 8-12 A ’s,
by the catalytic component of the CCR4-NOT complex, CCR4 (Chen et al., 2002). Next,
the DCP1/2 complex removes the 5’ cap with the assistance of additional proteins, such
as DHH1, EDC1, EDC2, LSM1-7, and PAT1 (Dunckley and Parker, 1999; Bouveret et
al., 2000; Schwartz et al., 2003; Bonnerot et al., 2000; Hilleren and Parker, 1999; He and
Parker, 1999; Hatfield et al., 1996). Following deadenylation and decapping, XRN1
then digests the mRNA in the 5’ to 3’ direction (Dahanukar et al., 1999). Also, a multicomponent complex, called the exosome, can digest the mRNA in the 3 ’ to 5 ’ direction
following deadenylation (Anderson and Parker, 1998; Mitchell et al., 1997). The
exosome complex can also digest mRNA, through the nonstop decay pathway, as a result
of a transcriptional error in which a stop codon has been skipped (Frischmeyer et al.,
2002; Beelman and Parker, 1995). Deadenylation independent mRNA degradation can
occur through two mechanisms. First, adenylated mRNA can be digested
endonucleolytically (Binder et al., 1994). Second, a nonsense-mediated decay (NMD)
pathway degrades mRNA containing a premature stop codon (Muhlrad et al., 1994; Cao
and Parker, 2001). NMD is thought to have evolved as a surveillance mechanism that

4
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quickly degrades aberrant mRNA containing premature stop codons in order to reduce
the number of truncated transcripts (Cali and Anderson, 1998). The first step of NMD is
decapping, followed by XRN1 mediated 5’ to 3’ exonucleolytic decay (Muhlrad and
Parker, 1994).
Several observations suggest that deadenylation is the rate limiting step of mRNA
degradation. First, sequences promoting rapid degradation also promote increased
deadenylation (Decker and Parker, 1993; LaGrandeur and Parker, 1999). Second, stable
transcripts have a much slower deadenylation rate compared to transcripts that degrade
rapidly (Decker and Parker, 1993; LaGrandeur and Parker, 1999). Lastly, decapping
does not occur until the poly(A) tail is approximately 8-12 A’s, which is the minimal
length of poly(A) that PAB1 can bind (Decker and Parker, 1993; Sachs et al., 1987).
Since deadenylation is the initial and rate limiting step in mRNA degradation,
understanding how deadenylation occurs will provide valuable insight into how mRNA
degradation occurs. CCR4 is of particular interest because it is responsible for the
majority o f deadenylation (Tucker et al., 2001). Further characterization of CCR4 will
provide valuable information about mRNA degradation. How CCR4 determines which
mRNA is to be deadenylated more quickly than others is an important area of study.
CCR4
The CCR4 gene was initially identified by Clyde L. Denis in 1984 as a block to
derepression of the ADH2 gene (Denis, 1984). Subsequent studies revealed that the
CCR4 protein contains an acidic activation domain at the amino terminus, a leucine rich
repeat region, and a deadenylase domain (Draper et al., 1994; Malvar et al., 1992). Two
activation domains present in the N-terminal region were shown to be able to activate

5
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LacZ expression when expressed from a GAL promoter, this shows that CCR4 has some
role in transcription initiation (Draper et al., 1994). However, deletion of upstream
ADH2 activation sequences did not affect CCR4 regulation of ADH2 expression,
indicating that CCR4 is involved in regulating ADH2 expression through mechanisms
other than simple activation (Denis and Malvar, 1990). The leucine rich repeat region
was shown to be important in blocking the derepression of ADH2 (Malvar et al., 1992).
However, since CCR4 is part of a multi-protein complex called the CCR4-NOT complex
and the LRR was shown to be important in contacting additional proteins in the CCR4NOT complex (Clark et al., 2004; Draper et al., 1994; Ohn et al., 2007) the function of
the LRR in ADH2 expression may be to simply contact the remainder of the complex.
Initially, the major role of CCR4 was thought to be in transcription initiation, whereby
the CCR4 activation domain was thought to play a part in transcription initiation and the
leucine rich repeat region was utilized to contact additional proteins involved in proper
promoter placement (Draper et al., 1994). Until recently, the C-terminal exonuclease
domain was largely unexplored, but in 2001 CCR4 was discovered to be responsible for
the majority of mRNA deadenylation in the cell (Chen et al., 2002; Tucker et al., 2001).
Additional components of the CCR4-NOT complex are CAF1, NOT1-5, CAF40,
and CAF130 (Chen et al., 2001). NOT1 serves as a scaffold for the CCR4-NOT
complex; CAF1, CAF40, CAF130 and the remaining NOTs all bind to NOT1 (Chen et
al., 2001). CAF1 acts as a bridge between CCR4 isolating it from the rest of the complex
(Bai et al., 1999). The NOTs were identified in a screen for genes capable of bypassing a
delta insertion in the HIS3 promoter, which indicates that they have a role in

6
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transcriptional initiation (Collart and Struhl, 1994; Collart and Struhl, 1993; Viswanathan
et al., 2004). NOT5 and NOT3 contact TFIID (Collart and Struhl, 1994; Lemaire and
Collart, 2000) and NOT4 appears to have ubiquitin ligase activity (Irie et al., 1994;
Albert et al., 2002) and a putative RNA binding motif. Genetic evidence also suggests
the involvement of the CCR4-NOT complex in transcriptional elongation (Denis et al.,
2001). Currently, CAF40 and CAF130 remain largely uncharacterized. What is also not
well understood is how the CCR4-NOT complex components work together to affect
deadenylation and how the rates of mRNA deadenylation are regulated. In particular, the
mechanism whereby CCR4 targets specific mRNA for faster or slower deadenylation
remains to be elucidated.
It has been shown that certain mRNA binding proteins, such as the PUF family of
proteins, act on specific target mRNA to suppress translation and activate deadenylation
(Crittenden et al., 2003; Olivas and Parker, 2000; Edwards et al., 2001; Wang et al.,
2002; Wang et al., 2001; Crittenden et al., 2002). Furthermore, it has been shown that
PUF3 and PUF5 interact with or require CCR4 to deadenylate mRNA (Olivas and Parker,
2000; Goldstrohm et al., 2007; Goldstrohm et al., 2006; Tucker et al., 2002; unpublished
data). How CCR4 works in concert with the PUF proteins is a particular area of interest.
CCR4 could work by a simple recruitment model, whereby RNA binding proteins, such
as the PUFs, bind specific mRNAs to bring them in contact with the deadenylase (Figure
2A). Another model suggests that factors causing mRNP disruption or rearrangement
could result in the stalling of translation initiation which could also allow degradatory
proteins access to the mRNA (Figure 2B). These models have been hypothesized to
explain how the PUF proteins work to suppress mRNA.

7
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UTR is bound by PUF3 which in turn binds mRNA degradation proteins. mRNA degradation is
accelerated by increasing the local concentration of mRNA degradation proteins around the
mRNA containing the PUF3 binding sequence.
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Figure 2B - mRNP disruption model of mRNA deadenylation. PUF3 binds the consensus
sequence located in the 3’ UTR. Through PUF3 interaction with mRNP components, disruption
of PAB1 - poly(A) binding occurs.
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Figure 2C - Simultaneous recruitment and mRNP disruption model of mRNA deadenylation.
PUF3 causes PAB1 dissociation from poly(A) and recruits mRNA degradation components.
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PUF Family of Proteins
The PUF protein family members all share a conserved RNA binding domain
capable of recognizing a consensus repeat consisting of four core ribonucleotides,
UGUR. The PUF name is derived from the two proteins first characterized; Pumilio, in
Drosophila melanogaster and FBF, found in Caenorhabitis elegans. The PUF family of
proteins consists o f at least four subfamilies (Spassov and Jurecic, 2003). The following
PUM family members share 49% sequence identity: Pumilio in Drosophila, Puf 8 and 9
in C. elegans, and PUM1 and PUM2 in mammals. The FBF subfamily shares -20%
sequence identity to the PUM family and its members consist of seven proteins found in
C. elegans and the PUF5 protein found in Saccharomyces cerevisiae. Another subfamily
sharing more similarity to PUM than FBF contains the PUF proteins found in plants and
PUF3 and PUF4 from yeast. The last subfamily with very distant sequence similarity
consists of the yeast proteins PUF1, PUF2, and PUF6.
Crystallography and mutational studies showed that the RNA binding domain of
the Pum protein in Drosophila forms a crescent in which hb mRNA binds to conserved
residues on the inner surface, whereas Nos and Brat bind to the outer surface along the
eighth repeat (Edwards et al., 2001; Wang et al., 2001; Muhlrad and Parker, 1999).
Strikingly, this C-terminal region has 78% and 79% sequence similarity to the
mammalian PUM1 and PUM2 genes (Spassov and Jurecic, 2002). This observation
suggests that the RNA binding region is the most important for function.
In the eukaryotes that PU F proteins h av e been identified, the biological roles are

very diverse. These roles range from stem cell maintenance, the mating switch in yeast

9
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and worm, embryological development, and a mitochondrial role. Clearly, PUF proteins
have various biologically important roles which will be addressed further.
Pum l and Pum2 are highly expressed in mouse fetal and adult hematopoietic stem
cells (Spassov and Jurecic, 2003) and PUM2 is expressed in human germline cells
(Nakahata et al., 2003). This is suggestive of a mammalian role for PUM in stem cells.
The FBF protein in C. elegans is responsible for translational repression of gld-1
mRNA, which prevents germline cell differentiation allowing for stem cell proliferation
(Crittenden et al., 2003; Crittenden et al., 2002). FBF is highly expressed in germline
stem cells and fbf-Hfbf-2 mutants do not have germline stem cells (Crittenden et al.,
2002). Another mRNA that FBF acts on is fem-3, which is involved in the sperm/oocyte
switch (Kraemer et al., 1999). The FBF protein in C. elegans works with NANOS-3 to
accomplish translational repression offem-3 mRNA (Kraemer et al., 1999), and represses
expression of gld-1 mRNA (Crittenden et al., 2002).
Drosophila is another system that may have a Pum involvement in stem cells.
Pum is highly expressed in germline stem cells and pum -/- stem cells undergo
uncontrolled differentiation (Lin and Spradling, 1997). Pumilio (Pum) plays a role in
establishing a hunchback (hb) protein gradient in the developing Drosophila embryo
necessary for proper abdominal segmentation (Murata and Wharton, 1995; Wreden et al.,
1997). A 32 ribonucleotide sequence called the Nanos recognition element (NRE) is
recognized by Pum. Translational repression and deadenylation of hb occurs when Pum
binds the NRE located in the 3’ UTR. It is important to note that Pum cannot accomplish
this suppression of hb without the proteins Nanos (Nos) and Brain Tumor (Brat)
(Edwards et al., 2001; Wang et al., 2002; Wang et al., 2001; van Hoof et al., 2000).

10
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Recognition of the hb NRE is accomplished independently of Nos and Brat and
complementation of a pum mutant is possible by Pum repeats alone (Wharton et al.,
1998).
In Saccharomyces, deadenylation of COX17 mRNA is dependent on PUF3 and
the PUF recognition sequence in the 3’UTR is essential for PUF3 mediated deadenylation
(Olivas and Parker, 2000; Jackson et al., 2004). Mutation analysis of PUF3 has indicated
that the outer surface is important for deadenylation of COX17 mRNA (Houshmandi and
Olivas, 2005) suggesting that contact with additional proteins is important for
deadenylation. Another PUF protein in Saccharomyces, PUF5, is required for
deadenylation of HO mRNA (Goldstrohm et al., 2007). The 3’UTR of HO has also been
shown to confer translational suppression when fused to the ADE gene (Tadauchi et al.,
2001). These results show that in yeast, both PUF3 and PUF5 suppress expression of
their target mRNA transcripts through acceleration of the deadenylation rate, and PUF5 is
capable of translation suppression of a chimeric mRNA. This indicates that PUF in yeast
is a suitable model for analyzing PUF function and is likely to exploit similar
mechanisms of action as those used in higher eukaryotes.
At the molecular level, PUF proteins are involved in proper protein expression at
a post-transcriptional level. It has been shown that PUF proteins are capable of
suppressing translation of specific mRNAs and promoting the deadenylation of target
mRNAs. The precise mechanism explaining how deadenylation is stimulated by the PUF
proteins remains to be discovered. Additionally, the mechanism whereby PUF proteins
suppress translation remains to be determined. Two models describing how PUF proteins
suppress expression are the recruitment model and mRNP disruption model.

11
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As described in the recruitment and mRNP disruption models in the CCR4 section
above, PUF proteins could act by contacting specific mRNA and mRNA degradatory
proteins thereby recruiting the degradatory proteins to specific mRNA or PUF could act
by contacting components of the mRNP complex thereby causing them to dissociate from
the mRNA allowing degradatory proteins access to the mRNA. A third model could be
envisioned which combines the recruitment model and mRNP disruption model (Figure
lc). PUF proteins could cause mRNP destabilization or rearrangement and
simultaneously bring mRNA degradation proteins to the mRNA. The mRNP disruption
model does provide a mechanism for the translational suppression caused by PUF
proteins. However, since translation initiation and mRNA deadenylation are linked
(Schwartz and Parker, 1999), it is possible that both models are correct. In order to
obtain more information for either model the proteins involved in translation need to be
further characterized. Information about the translational involvement of proteins
involved in mRNA degradation and components of the mRNP complex would shed more
light on how translation occurs, and specifically, prove or disprove the mRNP disruption
model.
CAF1
CCR4 associated factor (CAF1) was first identified in a screen for overproduction
of the mammalian a-amylase driven by a PGK promoter (Sakai et al., 1992). This gene
was termed PGK promoter overproduction, or POP2. POP2 was the first term for this
gene, but due to the association with CCR41 will refer to it as CAF1. Additional
phenotypes of the cafl allele are: a block in glucose derepression, temperature sensitivity,
sporulation defects, and reduced carbohydrate reserves.

12
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In the CCR4-N0T complex, CAF1 is the primary contact between CCR4 and the
NOT proteins (Bai et al., 1999). CAF1, being an RNase of the DEDD superfamily, has
deadenylase activity (Daugeron et al., 2001) and is required for deadenylase activity in
vivo (Tucker et al., 2001; Daugeron et al., 2001). However, mutations in the RNaseD
domain of CAF1 did not affect in vivo deadenylation activity (Viswanathan et al., 2004),
and a lesion in CCR4 caused a more severe block in deadenylation (Tucker et al., 2001).
This also suggests another role for CAF1, as the CCR4 protein is responsible for the
majority of cytoplasmic deadenylase activity (Tucker et al., 2002). Mutation of CAF1
residues important for CCR4 contact were shown to cause deadenylation defects, further
indicating CAF1 has a separate role in deadenylation from CCR4 (Ohn et al., 2007).
Clearly, the exact role o f CAF1 in mRNA deadenylation is unknown and further study of
this protein is necessary to determine its precise function.
A translational role for CAF1 has been suggested through two observations. First,
a cafl deletion displayed a synthetic lethality with PAB1-ARRM2 which can be rescued
by over-expression of STM1 and DHH1 (Ohn et al., 2007). STM1 has a role in
translation and makes contact with the ribosome (Van Dyke et al., 2006; Van Dyke et al.,
2004) and DHH1 has role in both decapping and translation (Coller et al., 2001;
Ladomery et al., 1997; Nakamura et al., 2001; Navarro et al., 2001). Second, over
expression of CAF1 rescues the lethality observed in a cdc33-l strain, which has defects
in the translation initiation factor eIF4E (Ohn et al., 2007). For the purpose of
determining if CAF1 has a role in translation and what that role is, I have measured in
vivo translation rates in a cafl A strain in combination with the cdc33-l allele and PAB1RRM2 variants, and over-expressed CAP I in a strain carrying the cdc33-l allele.
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Translation
Translation describes a process resulting in the conversion of mRNA into protein.
In all eukaryotes the 80S ribosome is responsible for translation. The 80S ribosome can
be divided into the two core components, the 40S and 60S ribosomes. Ribosomes are
composed of many proteins and several RNA. In yeast, all ribosomal proteins also have
a homolog in mammalian systems (Mager et al., 1997), so translation in yeast is probably
representative of translation in mammals. The yeast 60S ribosome is composed of 42
ribosomal proteins and three RNAs: 5S (121 nt), 5.8S (158 nt), and 25S (3392 nt). The
smaller 40S ribosome consists of 32 proteins and a 18s RNA (1798 nt). By weight, the
majority o f the ribosome is RNA, compared to protein. In the 60S ribosome, the RNA to
protein ratio is -61% to 39%, and the 40S subunit has a 54% RNA to 46% protein ratio
(Verschoor et al., 1998).
Translation begins with the formation of the 43 S complex, which occurs when
eIF2-GTP- Met-tRNAjMet binds the 40S ribosomal subunit. This process is facilitated by
the translation initiation factors, eIF3, elFl, and elFlA (Figure 3A). Binding of the 43S
complex with the mRNP complex through eIF4G occurs in mammals through eIF3, but
in yeast it is thought that eIF2 bridges the eIF4G-eIF3 interaction. When the 43 S
complex binds the mRNP complex the pre-initiation complex is formed, also called the
48S complex (Figure 3B). Hydrolysis of eIF2-GTP to eIF2-GDP occurs when the 48S
complex locates the AUG start codon. Dissociation of eIF3, elFl, elFl A, and eIF2
occurs following eIF2-GTP hydrolysis (Figure 3C). Following dissociation of eIF3,
elFl, elFlA, and eIF2 the 60S ribosomal subunit binds the 40S ribosomal subunit
forming the 80S ribosome (Figure 3D).
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Translational elongation of the polypeptide occurs through hydrolysis of GTP by
eEFl A when an aminoacyl-tRNA of the correct anti codon is brought to the A site of the
ribosome. Peptidyltransferase then catalyzes a peptide bond with the amino group of the
peptide in the P site. This process continues until a stop codon is reached. A stop codon
(UAA, UGA, or UAG) is recognized by eRFl (Frolova et al., 1994), and
peptidyltransferase catalyzes a bond to water instead of an aminoacyl-tRNA.
Dissociation o f the complete polypeptide, 40S, and 60S ribosomal subunits from the
mRNA occurs through the hydrolysis of GTP by eRF3 (Zhouravleva et al., 1995).
Deletion of the N terminal region of eRF3, which is the region responsible for
contacting PAB1, blocks PAN2/3 deadenylation but also appears to affect CCR4
dependent deadenylation (Hosoda et al., 2003). Mutation of the GTP binding motif in the
C-terminal region of eRF3 is required for association with eRFl and increases mRNA
degradation rates (Kobayashi et al., 2004). These last two observations link translational
termination with mRNA deadenylation.
In mammals, regulatory proteins, called 4E-binding proteins (4E-BPs) bind to
eIF4E. 4E-BPs blocks eIF4E contact to eIF4G which results in a block in translation.
The only 4E-BP in yeast is p20 (CAF20) which has been shown to competitively bind to
eIF4E and cause the similarly observed block in cap-dependent translation, as in
mammalian cells (Ptushkina et al., 1998). Over-expressed CAF20 displayed synthetic
lethality in backgrounds containing defect in eif-4e, eif-4a, eif-4, and eif-4g (de la Cruz et
al., 1997), further indicating a CAF20 role in translation initiation. One model suggests
that CAF20 inhibits translation by disrupting the mRNP complex. By over-expressing
CAF20 we can determine how perturbations in the mRNP structure affect translation.
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Another method to determine how the mRNP structure affects translation is by analyzing
defects in components of the mRNP structure. One such mRNP component suitable for
analysis is the poly(A)-binding protein, or PAB1.
PAB1
Initial identification of PAB1 in rabbit and mouse was through association with
the polysome (Blobel, 1972). In subsequent studies upon isolating PABP or PAB1
(poly(A) binding protein), it was shown to bind to the 3’ poly(A) tail of mRNA (Blobel,
1973). The PAB1 protein has four RNA Recognition Motifs (RRM1-4), an unstructured
Proline and Methionine rich region (P), and a globular C-terminal region (C). Contact
between eIF4G and PAB1 is made through RRM2, and the C terminal region makes
multiple protein contacts with: PBP1, eRF3, and the deadenylase PAN2/3 ((Hosoda et al.,
2003; Mangus et al., 2004; Mangus et al., 1998). A mature mRNA available for
translation is bound by multiple proteins into a complex called the mRNP complex. The
core components of the mRNP complex are eIF4E which contacts the 5’ cap of the
mRNA, PAB1 which binds the 3’ poly (A) tail, and eIF4G, which contacts PAB1 and
eIF4E causing the mRNA to form a loop (Wells et al., 1998; Jacobson and Peltz, 1996;
von Der Haar et al., 2000).
Since PAB1 is bound to mature mRNA in the cytoplasm, it is highly suggestive
that PAB1 plays a role in stability of the mRNA and/or translation of mRNA into protein.
One class of mutations allowing for viability of a pabl deletion are mutations in mRNA
degradation factors (Caponigro and Parker, 1995), suggesting a role for PAB1 in mRNA
degradation. Additionally, in vitro evidence showed PAB1 to inhibit mRNA
deadenylation (Tucker et al., 2002; Wilusz et al., 2001). However, in vivo, a pabl
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deletion resulted in mRNA with long poly(A) tails, suggesting that PAB1 has multiple
roles in deadenylation of mRNA (Caponigro and Parker, 1995). Since PAB1 has been
shown to play a role in mRNA biogenesis (Dunn et al., 2005), proper export of mRNA
from the nucleus (Brune et al., 2005), and adenylation of the 3’ end of mRNA (Dheur et
al., 2005), the inconsistency between the in vivo and in vitro observations could be due to
epistatic effects the p a b l deletion has on mRNA other than specific degradation of the
mRNA transcript. Alternatively, it has been suggested, that in a p abl deletion, non
specific RNA binding proteins associated with the poly(A) tail inhibit deadenylation.
The role of PAB1 in deadenylation is most likely an inhibitory one in terms of CCR4
action but it is also required for deadenylation.
Recent analysis of PAB1 has suggested a model whereby PAB1 self-association
results in reduced poly(A) binding, thereby accelerating deadenylation (Yao et al., 2007).
The model of PAB1 self-association to promote deadenylation is supported through three
observations. First, the two PAB1 domain deletions resulting in the most severe defect in
deadenylation are PAB1-ARRM1 and PAB1-AP (Yao et al., 2007). Second, these PAB1
domains are also necessary for the self-association or circularization of PAB1. Third, the
self-associated PAB1 binds poly(A) less efficiently compared to linear PAB1 (Yao et al.,
2007). This model indicates that PAB1 has an inhibitory role in deadenylation, and when
it dissociates from the poly(A), through self-association, deadenylation occurs. If PAB1
works through a general mechanism to inhibit all mRNA, then analysis of PAB1-ARRM1
and PAB1-AP should show a defect in deadenylation for a PUF3 controlled mRNA such
as COX17.
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Another class of mutations allowing for the viability of a pabl deletion are
defects in translational components, suggesting a PAB1 role in translation (Sachs and
Davis, 1989). It has been shown that deletion of RRM2 and RRM4 in PAB1 cause
decreased in vitro translation (Kessler and Sachs, 1998), furthermore substitution of
PAB1 RRM2 yeast residues with human residues showed defects in in vitro translation
(Otero et al., 1999). Tethering various PAB1 domains to a luceriferase-MS2 fusion
transcript has shown, in vivo, that specific regions of PAB1 are capable of stimulating
translation (Gray et al., 2000). Clearly, further analysis of PAB1 is necessary to
determine the exact role that it has on mRNA stability and translation.
One way to determine the function of PAB1 is to conduct a deletion analysis of
the protein. In order to understand the effect of mRNA binding, point mutations
abrogating the mRNA binding ability were created (Sachs and Deardorff, 1992). By
changing the order of the domains we were also able to gain insight into any positional
effects and possible linker interactions between the domains. Lastly, swaps between
human PABP1 domains and yeast PAB1 domains have been constructed in order to
determine which human residues have a different function in yeast. These PAB1 variants
were analyzed to determine additional information about how PAB1 involvement in
deadenylation and translation occurs.
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CHAPTER I

MEASUREMENT OF IN VIVO TRANSLATION RATES IN STRAINS CONTAINING
PAB1 VARIANTS, DEFECTS IN mRNA DEGRADATION COMPONENTS, AND
DEFECTS IN TRANSLATION COMPONENTS

Introduction
Gene regulation at the level of translation initiation is a very complex process. By
determining the exact mechanisms whereby translation occurs we hope to better
understand how the process is regulated. As reviewed in Sonenberg, 2003; Sachs et al.,
1997 (Sachs et al., 1997; Sonenberg and Dever, 2003), translation begins with
recruitment of the eIF2-GTP- Met-tRNA,Mct complex to the 40S ribosome, this is
facilitated by eIF3, elFl, and elFlA, thus forming the 43S complex (Figure 3A). The
48S complex forms when the 43S complex binds eIF4F, mRNA, and PAB1 (Figure 3B).
The 48S preinitiation complex then locates the AUG start codon which causes the
hydrolysis of eIF2-GTP to eIF2-GDP (Figure 3C). Hydrolysis of eIF2-GTP to eIF2-GDP
causes eIF2 to dissociate from the ribosome, followed by dissociation of the remaining
elFs (Figure 3C). After dissociation of all elFs from the ribosome, binding of the 40S
and 60S ribosomes occurs, resulting in a translationally competent 80S ribosome (Figure
3D).
It is known that the cap structure and the poly(A) structure have a synergistic
relationship which allows for efficient translation (Otero et al., 1999). In order to
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determine how the cap and poIy(A) structure function in translation we must analyze the
proteins associated with these structures. The most suitable candidates for analysis are
the core components of the mRNP complex: eIF4E, eIF4G, PAB1 (Jacobson A. and Peltz
S.W., 1996; von Der Haar T. et al., 2000). eIF4E and eIF4G both play a role in capdependent translation (Otero et al., 1999; Gross et al., 2003). However, eIF4G may
present a greater challenge due to the fact that two genes encode it, making it more
complicated for gene deletion analysis. As such, the temperature sensitive (ts) eIF4E
protein which is encoded by the cdc33-l allele may be more useful in understanding capdependent translation. PAB1 is known to play a role in both cap-dependent and poly(A)
dependent translation (Otero et al., 1999). In order to better understand cap-dependent
and poly(A) dependent mechanisms we have to understand the role that PAB1 has in
translation. PAB1 variants can be analyzed alone and in combination with the eIF4E
defect for the purpose of gaining additional insight into the function of PAB1 in
translation. By combining mutations in these two genes (eIF4E and PAB1) we provide a
system in which cap-dependent and poly(A) dependent translation are both defective,
thereby allowing us to better understand how these mechanisms operate to carry out the
translational process.
In order to gain additional insight into the role of PAB1 on translation analysis of
PAB1 defects with another translational defect other than eIF4E may be useful. A
temperature sensitive (ts) allele of eIF3 (encoded by prtl-63) is a particularly useful
strain because it represents a defect at a different site in translation than eIF4E.
Additionally, this allele has been previously studied by Schwartz and Parker (Schwartz
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and Parker, 1999): in the same procedure that I used to measure translation rates. The
eIF3 complex is involved in the joining step between the mRNP complex, ribosome, and
eIF2-GTP- Met-tRNAjMet (Jivotovskaya et al., 2006), which occurs before contact with
eIF4G is made. Additional evidence suggesting that eIF3 and eIF4G have different roles
in translation is supported by the observation that depleting eIF3 does not allow mRNA
accumulation on ribosomes, whereas depletion of eIF4G results in mRNA bound to
ribosomes but has defects in the 60S ribosomal subunit joining step (Jivotovskaya et al.,
2006).
The PAB1 domains seem to have discrete functions in translation, as suggested by
three observations. First, Sachs and colleagues has shown that RRM2 is involved in
contacting eIF4G, (Otero et al., 1999) which is also a core component of the mRNP
complex (Jacobson A. and Peltz S.W., 1996; von Der Haar T. et al., 2000; Wells et al.,
1998). The fact that the PAB1 RRM2 domain contacts eIF4G and that PAB1 RRM1 is
not directly involved in eIF4G contact while still having a role in translation suggests
PAB1 RRM1 and PAB1 RRM2 each have different roles in translation. Second, each of
the PAB1 RRMs have varying mRNA binding specificities and translational involvement
(Burd et al., 1991), also indicating a modular nature to the PAB1 protein. Third,
sequence similarity between domains RRM1-RRM4 within PAB1 (in yeast 25-43%) is
much lower than across species (61% amongst the PAB1 RRM1 domain; 64% amongst
the PAB1 RRM2 domain; 55 % for PAB1 RRM3 domain; 77% for PAB1 RRM4),
suggesting discrete conserved functions among the individual domains. Since deletion of
PAB1 is lethal and the various domains seem to serve different functions from one
another, analysis of the PAB1 protein containing a deletion of each domain is one way to
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better understand the function of the individual PAB1 domains and hence how the PAB1
protein functions.
Another method to determine the function of PAB1 in translation would be to
analyze the ability of each domain to stimulate translation, as performed by Wickens and
colleagues (Gray et al., 2000). Determination of PAB1 domains capable of stimulating
translational activity was done by injecting Xenopus laevis oocytes with a luciferase RNA
reporter containing a MS2 binding site and a fusion protein containing a PAB1 variant
fused to the MS2 protein (Gray et al., 2000). The MS2 protein recognizes and binds the
MS2 RNA binding site in the luciferase RNA (Withered et al., 1991), thus tethering the
PAB1 variant to the luciferase RNA. This analysis determined which portions of PAB1
are capable o f simulating translation, thus implicating those portions of PAB1 that are
involved in translation. If the identified portions of PAB1 are necessary for translation
then deletion of those domains should show a decreased translational rate in vivo and in
vitro, and PAB1 regions incapable of translation stimulation should not show any effect
on the translation rate. In vitro analysis of PAB1 domain deletions has been conducted
(Otero et al., 1999; Kessler and Sachs, 1998) and some results agree with the oocyte data,
but some results do not. Another analysis of PAB1 would help clarify what exactly the
role of PAB1 is with respect to translation. Using a set of PAB1 domain deletions I have
measured the in vivo translation rates in order to gain additional insight into the role of
eachPABl domain.
Other factors may also affect translation, including the proteins involved in
shortening the poly(A) tail, such as the CCR4-NOT deadenylase complex. Specifically,
CAF1 may play a role in aiding translation and can be surmised through three
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observations. First, lethality between a PAB1-ARRM2 and caflA has been observed (Ohn
et al. 2007), indicating a genetic interaction between a core component of the mRNP
complex, PAB1, and that of CAF1. Second, a screen for genes whose over expression
was capable of bypassing the lethality of the PAB1-ARRM2 caflA double mutant
identified the following genes: DHH1, STM1, SEC66, MSP1, OKP1, and POL4 (Ohn et
al. 2007). Homologs of DHH1 are involved in translational suppression (Ladomery et
al., 1997; Nakamura et al., 2001; Navarro et al., 2001), and STM1 contacts ribosomes and
is involved in translation following nitrogen starvation (Van Dyke et al., 2006; Van Dyke
et al., 2004). Because DHH1 and STM1 are capable of rescuing the PAB1-ARRM2 caflA
lethality and are involved in translation, this implies that a role for CAF1 in translation is
possible. Third, the cdc33-l allele, encoding a defect in eIF4E is lethal at 37°C, can be
rescued by over-expression of CAF1 (Ohn et al 2007).
In addition to CAF1, another member of the CCR4-NOT complex that may have
a role in translation is CCR4. There are four observations that suggest CCR4
involvement in translation. First, a link between mRNA deadenylation and translation
termination has been observed (Keeling et al., 2006). Second, the stress response slows
deadenylation and suppresses translation, which suggests a link between link between
deadenylation and translation (Hilgers et al., 2006). Third, deletion of the N terminal
region of eRF3 blocks deadenylation and interferes with translation termination (Hosoda
et al., 2003). Lastly, mutation o f the GTP binding motif in the C-terminal region o f eRF3
is required for association with eRFl and increases mRNA degradation rates (Kobayashi
et al., 2004). Since, the role of CAF1 seems to be more closely linked to CCR4 than
with the rest of the CCR4-NOT complex, CAF1 may have multiple roles, as with CCR4,
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one in deadenylation and another in translation. What is not well understood is how
CAF1 operates in translation and in deadenylation.
In order to show more definitively that CAF1 and CCR4 are involved in
translation and to help understand the role of each protein in translation, I have conducted
in vivo translation assays in caflA, ccr4A, alone and combined with cdc33-l, and also in
a cdc33-l background with over-expressed CAF1 and CCR4. In vivo translation rates
have also been measured in strains with defects in other mRNA degradatory proteins,
such as DCP1, DHH1, and PAN3. In order to better understand the relationship between
CAF1 and the RRM2 domain of PAB1, rates have been measured in RRM2 mutants
capable of rescuing the synthetic lethality combined with caflA mutants. For the
purpose of determining what the translational role of PAB1 is and how the interaction
between PAB1 with additional factors affects translation, I measured the translation rates
of the PAB1 variants combined with prtl-63, cdc33-l, ccr4A, and caflA.
Materials and Methods
Yeast Strains and Plasmids
Yeast strains are shown in Table 1. Plasmids used are shown in Table 2. Yeast
cells were inoculated into YEP medium (1% Bacto-yeast extract, 2% Bacto-peptone)
containing 2% glucose, and grown to exponential phase.
35S In Vivo Translation
In vivo translation was done in a similar fashion as previously described
(Schwartz and Parker, 1999). Five mL yeast cells were grown to exponential phase in
2% glucose YEP medium, the optical density at 600 nm was measured, then cells were
pelleted and resuspended in prewarmed 37°C met' medium (0.67% yeast nitrogen base
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without amino acids, and amino acids as required except methionine). Twenty five pCi
[35S] labeled methionine was then added to the resuspended cells in met' medium. At 10
and 20 minute time points, cold 10% trichloroacetic acid (TCA) was added to the
reaction, incubated for five minutes at 95 °C, and precipitated proteins were then
collected on nitrocellulose membrane filters. Filters were then washed with 10 mL 5%
TCA, and finally with 10 mL 70% ethanol. Following washing, filters were dried for 30
minutes, [35S] incorporation into protein was then measured in a liquid scintillation
counter. Using the Excel program, incorporated [35S] per optical density was determined
by dividing counts by the optical density for the strain. Rates were measured by dividing
the [35S] per optical density difference between time points by the difference between the
time points. Standard error of the mean (SEM) was used to determine if the rates were
significantly different. SEM was calculated by dividing the standard deviation by the
square root o f the total number of samples.
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Yeast Strains Used

Table 1
Strain

Relevant Genotype

AS31 QlpYC360

a ade2 his3 Ieu2 trp1 ura3 pab1::HIS3 [PAB1-URA3]

AS319lpYC504

Isogenic to AS319/360 except [PAB1-TRP1]

AS 188 MpYC504

Isogenic to AS319/360 except [PAB1-TRP1] cdc33-1

1743-2/p YC504

75% Isogenic to AS319/360 except [PAB1-TRP1] prt1-63

1729-3/p YC504

75% Isogenic to AS319/360 except [PAB1-TRP1] gst1-1

AS319-1 a-uN/p YC504
AS319-c1 -\WpYC504

Isogenic to AS319/360 except [PAB1-TRP1]
ccr4::ura3::NEO

Isogenic to AS319/360 except [PAB1-TRP1]
caf1 ::ura3::LEU2

AS319-dhh1uLlpYC504

Isogenic to AS319/360 except [PAB1-TRP1]

DB267lpYC504

Isogenic to AS319/360 except [PAB1-TRP1] pan3A

1754-1-tN lpYC504

Isogenic to AS319/360 except [PAB1-TRP1]
pan2::trp1::NEO

dhh1::ura3::LEU2

Source
Yao et al.,
2007
Yao et al.,
2007
Ohn et al.,
2007
C. Denis,
UNH
C. Denis,
UNH
Yao et al.,
2007
Ohn et al.,
2007
Hata et al.,
1998
Yao et al.,
2007
Yao et al.,
2007

Strains were obtained from various sources as indicated by the reference. 1743-2 and 1729-3
were derived from crosses conducted by Clyde Denis.
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Table 2

Plasmids Used

Plasmid

Relevant Genotype and Marker

Source

PYC504

PAB1 [TRP11

Yao et al., 2007

PYC460

PAB1-APC [TRP11

Yao et al., 2007

PYC505

PAB1-ARRM1 [TRP11

PYC506

PAB1-ARRM2 [TRP11

Yao et al., 2007
Yao et al., 2007

PYC507

PAB1-ARRM3 [TRP1]

PYC508

PAB1-ARRM4 [TRP1]

Yao et al., 2007
Yao et al., 2007

pYC509

PAB1-AC [TRP1]

Yao et al., 2007

pYC510

PAB1-AP [TRP11

Yao et al., 2007

pYC513

PAB1 -1212PC [TRP11

Yao et al., 2007

PYC525

PAB f-Y170V [TRP11

Yao et al., 2007

PYC536

P4B1-F83V [TRP1J

Yao et al., 2007

PYC537

R4B1-F83V Y170V [TRP1]

Yao et al., 2007

PYC538

R4B7-184 [TRP1]

Yao et al., 2007

pYC545

PAB1 -134 [TRP1]

Yao et al., 2007

pYC551

P4B1-F366V [TRP1]

PYC552

PAB 1-F263V [TRP1 7
P4B1-1214PC [TRP1]

Yao et al., 2007
Yao et al., 2007
Yao et al., 2007

PYC570

PAB1-hRRM3 [TRP11

Yao et al., 2007

PYC571

PAB1-1224PC [TRP1]

Yao et al., 2007

PYC572

PAB1-1232PC [TRP1J

Yao et al., 2007
Hata et al., 1998
Hata et al., 1998

pYC562

YEp13

[LEU 2]

YEpMPTO

CAF1 [LEU2]

YEpMPT2

CCR4 [LEU21

Hata et al., 1998

GALp-COX17 [LEU2]

Olivas and Parker, 2001

PRP1007

Plasmids designatedpYC were constructed by Yueh-Chin Chiang and used for previous
analysis in Yao et al., 2007. Other plasmids were obtained from the indicated source.
All plasmids were transformed into the indicated strain by the LiOAc method (Ito et al.,
1983).
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Results

Effects of Defects in mRNA Degradative Proteins on In Vivo Translation
The determination of the accuracy of the in vivo translation assay that I performed
was ascertained by comparison of the translation rate with previously determined rates,
such as that determined for the cdc33-l allele measured by Schwartz and Parker
(Schwartz and Parker, 1999). All reported translation rates represent the average of two
or more samples compared to the PAB1 wild type strain and all compared strains are
isogenic to the PAB1 wild type strain, except for 1729 (contains gstl-1 allele) and 1743
(containsprtl-63 allele) which are 75% isogenic. Defects in eIF4E are encoded by the
temperature sensitive allele, cdc33-l, which displayed an average translation rate of 29%
compared to wild type (Figure 4, Table 3). As mentioned in the introduction, eIF4E, is
the mRNA cap binding protein involved in cap mediated translation (Jacobson A. and
Peltz S.W., 1996; von Der Flaar T. et al., 2000; Wells et al., 1998). A decreased
translation rate was therefore expected in the strain carrying the cdc33-l allele. The
slightly lower rate of translation in a cdc33-l strain (19%) that was determined
previously (Schwartz and Parker, 1999) could be due to the differences among the strain
backgrounds used. My results showed an in vivo translation rate of 45% for the prtl-63
strain (Figure 4, Table 3). This decreased rate was expected, since at 37°C the prtl-63
allele causes in vitro and in vivo defects in the translation initiation factor eIF3 (Phan et
al., 2001; Jivotovskaya et al., 2006; Searfoss et al., 2001). The d iscrepancy b etw een m y

in vivo translation rate (45%) and the previously reported in vivo translation rate (8%)
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(Schwartz and Parker, 1999) could be caused by two factors. First, the wild type and
prtl-63 strains are only 75% isogenic, which could result in an error when normalizing
the prtl-63 strain to wild type. Second, the strain I used and the strain previously used by
Schwartz and Parker have different backgrounds. What is important is the observation
that prtl-63 caused a decrease in translation, indicating that the assay is functioning
properly to show a decreased translation rate when one is expected. The translation
termination factor eRF3 is encoded by GST1, and the gstl-1 allele confers temperature
sensitivity (Hosoda et al., 2003). The strain, containing the gstl-1 allele, did not show as
much decrease in translation rate (62%) as did defects in the translation initiation factors
(Figure 4, Table 2). Since it is known that translation termination, mRNA deadenylation,
and translation initiation are related (Hosoda et al., 2003; Kobayashi et al., 2004;
Schwartz and Parker, 1999), it is expected that the decreased rate in a gstl-1 strain was
observed. Similiarly, with the exception of the caflA deletion, which displayed 35% of
the translation as of wild type, defects in other mRNA degradation factors all have less
severe effects on the rate of translation (in the range of 45-78%, Figure 4, Table 3)
compared to the rates observed for the translation initiation deficient strains (ts eIF4E:
29%, ts eIF3: 45%). Since some of these were rates comparable to prtl-63, it indicates
that factors involved in mRNA degradation affect in vivo translation. These observations
suggest that the assay is functioning properly and should be useful to determine if
additional mutations have significant major defects in translation. CAF1 displayed the
most severe defect on in vivo translation and was analyzed further.
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In Vivo Translation Rates of Defective Translation

Com ponents and mRNA Degradation Com ponents
1 2 i --------------------- --------------------------------------------------------------------------------

1

-

PAB1

cdc33-1 prt1-63

ccr4A

caflA

pan3A

dhhlA

gst1-1

pan2A

Figure 4 - In vivo translation rates of cdc33-1, prt1-63 , PAB1, dcplA, ccr4A, pan3A, dhhl A, and
gst1-1. Values are averages of mutant relative to wild type PAB1 and SEMs are shown as error
bars. SEM is the standard error of the mean, and was calculated by dividing the standard
deviation by the square root of the number of samples. All calculations were done with Microsoft
Excel software.
Relevant Genotype Mean (rate/WT)
Strain
PAB1
AS319 lpYC504
100%
cdc33-1
29%
AS 188 MpYC504
37%
1743lpYC504
prt1-63
55%
AS319-1 alp YC504
ccr4A
caflA
35%
AS319-C1 lpYC504
DB267lpYC504
pan3A
78%
52%
AS319-dhh1 AlpYC504
dhhlA
1729-3lpYC504
gst1-1
62%
45%
1754-1 -tN/p YC504
pan2A
Table 3 Absolute values and number of samples run for Figure 4.

SEM
4%
7%
5%
2%
11%
0%
9%
3%

Samples
2
12
2
7
7
2
2
3
2
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Translation Rates in PAB1 Domain Deletions
To determine if domain deletions in PAB 1 or PAB1 variants cause major defects
in translation or if they have only minor effects, I measured the in vivo translation rate of
PAB1 variants and domain deletions. If the translation rate of a PAB1 domain deletion
or variant was similar to the translation rate of a defect in translation initiation factors
eIF3 and eIF4E, then the PAB1 domain or variant probably had a major role in
translation. However, most individual domain deletions and the PAB1 variants had only
minor effects on translation (Figures 4 and 5, Tables 3 and 4). Analysis of PAB 1 variants
and domain deletions displayed translation rates ranging from 70% to 112% of wild type
(Figure 5, Table 4). Since the translation rate of translation initiation factors, ts eIF4E
and ts eIF3, was 29% and 45% of wild type, this group of PAB 1 variants and domain
deletions was not as deficient in translation as with a defect in eIF4E or eIF3, which
suggested that deletion of individual domains of PAB 1 did not have a major role in
translation.
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Effect of PAB1 Variants on In Vivo Translation
1.4
1. 2

-

co

Figure 5 - Values are averages of the indicated PAB1 variant or domain deletion relative to wild
type PAB1. Error bars represent SEM. SEM is the standard error of the mean, and was
calculated by dividing the standard deviation by the square root of the number of samples. All
calculations were done with Microsoft Excel software.
Strain
AS319 lpYC504
AS319 lpYC505
AS319lpYC536
AS319 lpYC506
AS319 lpYC525
AS319 lpYC545
AS319 lpYC538
AS319 lpYC537
AS319lpYC507
AS319 lpYC552
AS319lpYC570
AS319 lpYC508
AS319 lpYC551
A S 319 /p Y C 5 1 0

Relevant Genotype

Mean (rate/WT)
100%
72%
90%
85%
81%
112%
96%
73%
99%
89%
74%
99%
100%

PAB1
PAB1-ARRM1
PAB1-Y83V
PAB1-ARRM2
PAB1-F170V
HPD134DKS
DAL184EKM
PAB1-Y83V, F170V
PAB1-ARRM3
PAB1-F263V
PAB1-hRRM3
PAB1-ARRM4
PAB1-F366V
PAB1-AP
PAB1-AC
PAB1-APC
PAB1-1214PC
PAB1-1224PC
PAB1-1232PC
PAB1-1212PC

94%

AS319lpYC509
102%
AS319/pYC460
94%
AS319lpYC562
110%
AS319/pYC571
70%
88%
AS319 lpYC572
AS319 lpYC513
98%
Table 4 Absolute values and number of samples run for Figure 5.

SEM

10%
13%
14%

Samples
4
4
3
4
3
4
3
4
3
4
3
4
3

6%

3

6%

3
4
4
3
3
3

8%
12%
3%
15%
27%
5%
14%
12%
13%

5%
11%
14%

11%
12%
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Translation Rates in the PAB1 RRM1 domain
PAB1-ARRM1 was shown to significantly lower the in vivo translation rate
compared to wild type (72%). When injected into oocytes, tethered PAB1 RRM1/2
domains were capable of stimulating translation more than any other domain compared to
tethered full length PAB1, suggesting the PAB1 RRM1/2 domains have a greater role in
translation than any other PAB1 domain (Gray et al., 2000). If PAB1 RRM1/2 domains
are necessary for translation, then deletion o f either PAB1 RRM1 domain or PAB1
RRM2 domain should decrease the in vivo translation rate, which is what I observed for
the in vivo translation rate in the PAB1-ARRM1 strain. However, in vitro the capdependent translation and poly(A)-dependent translation for PAB1-ARRM1 displayed a
significant increase (Otero et al., 1999; Kessler and Sachs, 1998) which is inconsistent
with my results. In order to determine if the PAB1 RRM1 domain contact to poly(A)
was necessary for the PAB1 RRM1 requirement for in vivo translation, a point mutation
in PAB1 RRM1 known to make RNA contact (Y83V) was analyzed. PAB1-Y83V
resulted in reduced binding to the poly(A) tail as compared to wild-type PAB1 (Yao et
al., 2007; Deardorff and Sachs, 1997). PAB1-Y83V, however, did not have a significant
effect on the in vivo translation rate (90%).
Translation Rates in PAB1 RRM2 Variants
PAB1-ARRM2 was shown to significantly lower the in vivo translation rate
compared to wild type (85%). A PAB1 RRM1 domain deletion and a PAB1 RRM2
domain deletion resulted in the larger decreases for in vivo translation rates compared to
other domain deletions (Figure 5, Table 4). This observation suggests that PAB1 RRM1
and PAB1 RRM2 have a more important role in translation than the other domains, and
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should be able to stimulate translation if tethered to a luciferase reporter. When PAB1
RRM1/2 tethered to a luciferase reported, translation was stimulated more than any other
tethered PAB1 domain (Gray et al., 2000). In vitro, PAB 1-ARRIVE was previously
shown to have a greater than four fold decrease for both cap-dependent translation and
poly(A) dependent translation compared to wild type (Otero et al., 1999), which is
inconsistent with my observed in vivo translation rate for PAB1-ARRM2 of 85% of wild
type. Furthermore, the in vitro translation rate for poly(A)-dependent and cap-dependent
PAB1-ARRM2 was previously determined to be more than two fold lower than for PAB1ARRM1 (Otero et al., 1999; Kessler and Sachs, 1998), which is inconsistent with my
determined in vivo translation rates, in which PAB1-ARRM2 resulted in 85% of wild type
and PAB1-ARRM1 resulted in 72% of wild type (Figure 5, Table 4).
In order to better understand the role of PAB1-RRM2 in translation, three variants
in the PAB1 RRM2 domain were analyzed. PAB 1-FI70V is defective in binding
poly(A) (Deardorff and Sachs, 1997). PAB 1-184 carrying the mutations DAL to EKM
fails to bind eIF4G in vitro (Otero et al., 1999) although in vivo it is still able to make
contact to eIF4G, albeit to a lesser extent (Y.C. Chiang, personal communication) and
PAB1-134 has the mutations HPD to DKS. The measured in vivo translation rate of a
point mutation in PAB1 RRM2 important for RNA binding (F170V) (Yao et al., 2007;
Deardorff and Sachs, 1997) was 81%. However, the SEM of 15% indicates that
additional samples are needed to determine if the decreased rate is significant. This
preliminary observation suggests that the PAB1 RRM2 poly(A) contact is important for
translation. In vitro PAB 1-184 showed an increase in cap-dependent translation
compared to PAB1-ARRM2 and was as defective in poly(A)-dependent translation as

36

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

PAB1-ARRM2, indicating that PAB 1-184 is defective in poly(A) dependent translation
and capable of stimulating cap-dependent translation (Otero et al., 1999). The PAB 1-184
in vivo translation rate was determined to be 96%, which is in agreement with the in vitro
translation rate for cap-dependent translation but in disagreement with the in vitro
translation rate for poly(A)-dependent translation. The in vitro translation rate for PAB1134 was similar to PAB1-ARRM2 for cap-dependent translation but poly(A)-dependent
translation was increased more than four fold compared to PAB1-ARRM2 (Otero et al.,
1999). The in vivo translation rate for PAB 1-134 was measured at 112% which is in
agreement with the in vitro poly(A)-dependent translation rate, but disagrees with its
effect on the in vitro cap-dependent translation rate (Otero et al., 1999).
Translation Rates in PAB1-RRM3
Deletion o f the complete region of PAB1-RRM3 had no effect on in vivo
translation (99%) compared to wild type. Tethering of PAB 1 RRM3/4 to a luciferase
reporter decreased translation slightly (93%) compared with tethered full length PAB1
(Gray et al., 2000). This indicates that PAB1 RRM3/4 does not have a large role in
translation. If the PAB1 RRM3/4 domains do not play a role in translation, then deletion
of PAB 1 RRM3 or PAB1 RRM4 should show no significant change in the in vivo
translation rate, which is what is observed for both domains (see next section for PAB1ARRM4 data). In vitro, the deletion increased poly(A)-dependent and cap-dependent
translation (Otero et al., 1999; Kessler and Sachs, 1998). A point mutation (F263V) in
the PAB1 RRM3 domain important for binding RNA (Yao et al., 2007; Deardorff and
Sachs, 1997) had no significant effect on in vivo translation (89%), further suggesting the
PAB1 RRM3 domain is unimportant for translation. However, substitution of the PAB1
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RRM3 domain with the PAB1 RRM2 domain (PAB1-1224PC) gave 70% of the wildtype in vivo translation rate. This was the largest decrease for in vivo translation rate
observed in the PAB1 domain deletions and variants (Figure 5, Table 4). In contrast,
substitution of the PAB1 RRM3 domain with the PAB1 RRM1 domain (PAB1-1214PC)
showed an in vivo translation rate of 110%. The PABl-hRRM3 variant did show a
decreased in vivo translation rate of 74%. However, as no other human PAB1 domain
substitutions were available at the time, it was not possible to compare this result to other
human PAB 1 domain substitutions.
Translation Rates in PAB1-RRM4. PAB1-P, PAB1-C Deletions
Analysis of the translation rates for PAB1-ARRM4 (99%), PAB1-AP (94%),
PAB 1-AC (102%), and PAB1-APC (94%) showed no significant differences compared to
the wild-type PAB1 strain (Figure 5, Table 4). Additionally, mutation of a PAB1 RRM4
residue (Y366V), important for RNA contact (Yao et al., 2007; Deardorff and Sachs,
1997) further indicates that changes in the PAB1 RRM4 domain do not affect in vivo
translation. Previous in vitro translation rates indicate that deletion of the PAB1 RRM4
domain decreased cap-dependent and poly(A) dependent translation (Otero et al., 1999;
Kessler and Sachs, 1998), which is inconsistent with my in vivo translation rate. Previous
analysis of the C terminus of PAB 1 was done with a truncation of both PAB1 P/C
domains which showed cap-dependent translation to be higher than wild type (Otero et
al., 1999) and lower than wild type for poly(A)-dependent translation (Kessler and Sachs,
1998). The in vivo translation rates I determined for the PAB1-AP, PAB1-AC, and PABJAPC strains were consistent with the in vitro PAB1-APC cap-dependent rate but
inconsistent with the poly(A)-dependent rate. In vivo translation rates measured with
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injected oocytes showed that tethered PAB1 PC domains were less capable of stimulating
translation compared to the full length PAB1, indicating the PAB1 P and PAB1 C
domains have no role in translation or act to suppress translation (Gray et al., 2000). If
PAB1 P and PAB1 C domains act to suppress translation then deletion of the domains
should increase the rate of translation, whereas if PAB1 P and PAB1 C domains have no
role in translation then deletion of either domain should not affect the in vivo translation
rate. The latter hypothesis agrees with the in vivo translation rates that I observed for
PAB1-AP, PAB1-AC, and PAB1-APC.
Translation Rates in ts eIF3 with PAB1 Variants
In vivo translation rates were measured in a strain with the prtl-63 allele and
PAB1 domain deletions. The following rates of translation were observed: PAB1ARRM1 (56%), PAB1-ARRM2 (44%), PAB1-ARRM3 (39%), PAB1-ARRM4 (44%),
PAB1-AP (50%), and PAB1-AC (42%) (Figure 6, Table 5). Compared to the prtl-63
allele alone (45%) the translation rates for the PAB1 domain deletions and almost all
PAB1 variants in the presence of prtl-63 displayed no significant difference (Figure 6,
Table 5). The only significant difference was for PABl-f34 (31%) that was much lower
than prtl-63 alone (45%). More determinations would be needed to verify that
observation, but it does suggest that the lesion in PAB1-134 functionally interacts with
eIF3 to decrease translation.
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Effect of PAB1 Variants and ts-elF3 on In Vivo
Translation
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Figure 6 - Average values for prt1-63 with PAB1 variants and domain deletions. Values are
relative to the wild-type parent strain. Error bars represent SEM. SEM is the standard error of
the mean, and was calculated by dividing the standard deviation by the square root of the number
of samples. All calculations were done with Microsoft Excel software.
Mean (rate/WT)
Relevant Genotype
Strain
PAB1
100%
AS319 lpYC504
prt1-63 PAB1
37%
1743lpYC504
prt1-63 PAB1-ARRM1
56%
1743!pYC505
prt1-63 PAB1-Y83V
44%
1743lpYC536
prt1-63 PAB1-ARRM2
38%
1743/pYC506
prt1-63 PAB1-F170V
30%
1743/pYC525
prt1-63 PAB1-Y83V,F170V
25%
1743lpYC537
prt1-63 HPD134DKS
31%
1743/pYC545
prt1-63 DAL184EKM
38%
1743lpYC538
prt1-63 PAB1-ARRM3
39%
1743lpYC507
prt1-63 PAB1-ARRM4
44%
1743lpYC508
prt1-63 PAB1-AP
50%
1743/p YC510
42%
prt1-63 PAB1-AC
1743/pYC509
p rt1 -6 3 P A B 1 - 1 2 1 2 P C
30%
1743/pYC513
Table 5 Absolute values and number of samples run for Figure 6.

SEM
7%
6%
4%
5%
6%
5%
4%
8%
3%
5%
3%
4%
3%
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Samples
2
2
2
2
2
2
2
2
2
2
2
2
2
2

Translation Rates in ts eIF4E with PAB1 Variants
Translation rates measured in the cdc33-l background varied from day to day so
in order to confirm a significant difference, the rates obtained for a sample on a specific
day or set of days had to be compared against the observed cdc33-l rate for the same
specific day or set of days as the sample being analyzed. The average in vivo translation
rate obtained for the cdc33-l allele alone (29%, Figure 7, Table 6) was taken from 12
samples. Since this average is taken from a large sample size it was considered to be
representative o f the affect of cdc33-lon translation. The average in vivo translation rates
for the remaining PAB1 variants and deletions in the cdc33-l background were taken
from two to seven samples. If in vivo translation rates for a particular variant were
measured outside the mean, those values were compared with rates for the wild type
PAB1 in the cdc33-l background on the same day. PAB1-134 (15%, Figure 7, Table 6)
in a cdc33-l background showed an average rate significantly lower than the mean
translation rate of the cdc33-l allele alone (29%, Figure 7, Table 6). However, as the
translation rates varied from day to day, cdc33-l PAB1-134 rates were measured at 14%
and 17% (data not shown) and on the same days the translation rates for the cdc33-l
allele alone were measured at 12% and 14% (data not shown), indicating that the PAB1134 protein does not affect translation significantly in a cdc33-l strain. cdc33-l PAB1ARRM4 showed an in vivo translation rate of 15% (Figure 7, Table 6) with SEM of 4%,
which is significantly lower than cdc33-l PAB1. However, on the same day that cdc33-l
PAB1-ARRM4 was analyzed, cdc33-l PAB1 showed in vivo translation rates of 16%,
19%, 20%, and 21%, averaged to 19% with SEM of 1% (data not shown) which indicates
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that cdc33-l PAB1-ARRM4 is not significantly different from the mean. In an effort to
better understand the interaction between eIF4E and the PAB1 RRM2, domain we then
analyzed the in vivo translation rate of the PAB1-184 protein (14%, Figure 7, Table 6),
which is significantly lower than the cdc33-l allele alone (29%, Figure 7, Table 6). In
contrast, when compared against another mutation in the RRM2 domain of PAB1
(FI70V, Table 2), which results in decreased mRNA contact, showed no difference in
translation rate (22%, Figure 7, Table 6) compared to the cdc33-l allele alone (29%,
Figure 7, Table 6). The remaining PAB1 variants do not show any significant difference
compared to the cdc33-l allele (Figure 7, Table 6). These observations indicate that
PAB1-184 caused a reduced in vivo translation rate when combined with a defect in the
cap binding protein, eIF4E. It has been shown that, in vitro, PAB1-184 is incapable of
binding eIF4G (Otero et al., 1999) and since eIF4G is responsible for contacting
additional translation initiation complexes (Neff and Sachs, 1999; Dominguez et a l,
1999) it is logical that abrogating contact between both the cap (eIF4E) and poly(A) tail
(PAB1-184) to eIF4G would cause a greater impairment to translation.
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Effect of PAB1 Variants and ts-elF4E on In Vivo
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Figure 7 - Average values for cdc33-1 with PAB1 mutations. Values are relative to the wild-type
parent strain.
Mean (rate/WT)
SEM
Samples
2
PAB1
100%
4%
12
cdc33-1 PAB1
29%
2
cdc33-1 PAB1-ARRM1
2%
22%
5
cdc33-1 PAB1-F170V
5%
22%
2*
cdc33-1 HPD134DKS
1%
15%
5
cdc33-1 DAL184EKM
14%
3%
2
cdc33-1 PAB1-ARRM3
6%
23%
4%
2*
cdc33-1 PAB1-ARRM4
15%
7%
2
cdc33-1 PAB1-AP
28%
2
cdc33-1 PAB1-AC
22%
1%
ASt88M pYC509
Table 6 - Average values for cdc33-1 with PAB1 mutations and domain deletions. The strains
indicated by * show a significant decrease in the mean, however comparison with the cdc331/PAB1 rate obtained on the same day was not significantly different.
Strain
AS319 lpYC504
AS 188 MpYC504
AS 1881 lpYC505
AS 188 MpYC525
AS 1881 lpYC545
AS 1881/0/0538
AS 188 MpYC507
AS 188 MpYC508
AS1881/p YC510

Relevant Genotype
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Analysis of CCR4 and CAF1 Effects on Translation

CCR4 and CAF1 are two components of the CCR4-NOT deadenylase complex
shown to play a role in deadenylation. When deleted, cafl and ccr4 showed in vivo
deadenylation defects (Tucker et al., 2001). Defects caused by a cafl deletion can be
rescued by over-expression of CCR4. However, defects associated with a ccr4 deletion
cannot be rescued by over-expression of CAF1 (Tucker et al., 2001; Chen et al., 2002;
Tucker et al., 2001). Moreover, mutation of predicted key catalytic active sites in CAF1
did not affect in vivo deadenylase activity (Viswanathan et al., 2004), whereas point
mutations in the predicted catalytic active sites in CCR4 does cause a defect in
deadenylation (Chen et al., 2002). Genetic evidence suggests that CAF1 plays a role in
translation, whereas CCR4 does not (Ohn et al., 2007; Coller and Parker, 2005; Maillet
and Collart, 2002). These observations suggest that CAF1 and CCR4 have different roles
in deadenylation and translation.
In order to determine if in fact CCR4 and CAF1 have functions in translation we
asked whether or not cafl A and ccr4A strains show a decreased translation rate. A
decrease in translation rate was observed for both CCR4 and CAF1, 55% for ccr4A and
35% for cafl A. This indicates that both CCR4 and CAF1 have roles in translation, but
CAF1 is more critical for translation than CCR4. Since it has been shown that a cafl
deletion is lethal when combined with PAB1-ARRM2 and a ccr4 deletion is viable when
combined with PAB1-ARRM2, we then asked how the PAB1 RRM2 variants affect in
vivo translation rates when combined with cafl A and ccr4A. When expressed in a cafl A
strain, PAB1-184 raised the translation rate to 50%. PAB1-134, in contrast, displayed
little effect when combined with cafl A and resulted in a rate of 30%. In a ccr4A
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background both PAB1-184 and PAB1-134 decreased the in vivo translation rate to 38%
and 46%, respectively (Figure 8, Table 7). These results suggest that the PAB1-184
mutations rescue the defect in translation caused by cafl A.
The synthetic lethality observed when combining a cafl A with the PAB1 domain
deletion PAB1-ARRM2 suggests that CAF1 has a similar translational role as eIF4E
because the cdc33-l allele also displayed a synthetic lethality with PAB1-ARRM2
(unpublished results). Because of this observation we asked how the cdc33-l allele
affects the translation rate in a cafl A or cc,r4A background. In the cdc33-l cafl A strain
we saw a much lower in vivo rate of translation (13%) than cdc33-l ccr4A (24%).
Compared to the cdc33-l allele alone (29%), cdc33-l cafl A has a more significant effect
on in vivo translation than cdc33-l ccr4A, implying that CAF1 and CCR4 have different
roles in translation. Previous deadenylation data regarding CAF1 and CCR4 imply the
two proteins have a role in deadenylation, albeit apparently, separate roles (Ohn, et al.
2007). My data suggests that CAF1 and CCR4 do in fact have roles in translation, but
those roles are separate as well as the roles in deadenylation.
Since over-expression of CAF1 rescues the lethality of the cdc33-l allele (Ohn, et
al. 2007), and since the cdc33-l allele confers a defect in the translation initiation factor
eIF4E it is reasonable to imagine that CAF1 rescues the cdc33-l lethality by increasing
the rate in translation when over-expressed. If, in fact, CAF1 has a role in translation
similar to eIF4E, then we would expect that over-expressed CAF1 would increase the rate
o f translation in a strain with the cdc33-l allele. CAF1 and CCR4 were over-expressed
from a YEpl3 plasmid which was introduced into a strain carrying the cdc33-l allele.
The in vivo translation rate of cdc33-l/YEpl3-CAFl was measured and normalized to the
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wild type parent strain with a YEpl3 plasmid, cdc33-HYEpl3. In order to determine if
CCR4 has a different role in translation than CAF1, the in vivo translation rate of over
expressed CCR4 was also measures in a strain carrying the cdc33-l allele. The cdc33-l
allele alone, cdc33-l/YEpl3 showed an in vivo translation rate of 38% ±7% (Figure 8,
Table 7), cdc33-l/YEpl3-CCR4 (31%±7%, Figure 8, Table 7) and cdc33-l/YEp!3-CAFl
(49%±6%, Figure 8, Table 7) did not show a significant difference compared to the
cdc33-l allele alone, due to overlapping SEM values. This suggests that over-expressed
CAF1 does not rescue a lesion in eIF4E by increasing in vivo translation rates.
Furthermore, this observation indicates that CCR4 does not have a significant
translational effect when combined with a defect in eIF4E. Although, these results do not
show that over-expressed CCR4 and CAF1 significantly increase or decrease in the rate
o f translation from the translation rate of the cdc33-l allele alone, the in vivo translation
rates for cdc33-l/YEpl3-CCR4 and cdc33-l/YEpl3-CAFl are significantly different from
one another. This suggests that over-expressed CAF1 and over-expressed CCR4 affect
the translation rate differently when combined with a defect in eIF4E, supporting the
hypothesis that CAF1 and CCR4 do in fact have different roles in translation.
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Effect of CAF1 and CCR4 on PAB Variants and ts
elF4E on In Vivo Translation
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Figure 8 - Values are the average of the rate relative to the wild-type parent strain. Error bars
represent SEM.
Strain
AS319 lpYC504
AS319-1 a/p YC504
AS319-1a lpYC545
AS319-1 a/p YC538
AS1881-1 a/ pYC504
AS319-c1/p YC504
AS319-C1 ipYC545
AS319-c1 Ip YC538
AS 1881 -c1 JpYC504
AS1881/YEpf3
AS1881//WPT2
AS1881//WPTO

Relevant Genotype
PAB1
ccr4A PAB1

Mean (rate/WT)
100%
55%
46%
38%
24%
35%
30%
50%
13%
38%
31%
49%

ccr4A HPD134DKS
ccr4A DAL184EKM
cdc33-1 Acer4
caflA PAB1
caflA HPD134DKS
caflA DAL184EKM
cdc33-1 Acafl
cdc33-1 YEp13
cdc33-1 YEp-CCR4
cdc33-1 YEp-CAF1

SEM
5%
14%
7%
4%
2%
8%
6%
4%
7%
7%
6%

Samples
4
7
4
3
3
7
3
3
3
4
3
4

T a b le 7 A b s o lu te v a lu e s a n d n u m b e r o f s a m p le s run for F ig u re 8.
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Discussion
Previous studies analyzing the role of PAB1 in translation have been limited to in
vitro studies (Otero et al., 1999; Kessler and Sachs, 1998) and the ability of PAB1
domains to stimulate translation (Gray et al., 2000). The in vitro studies have been useful
for determining a link between the PAB1 RRM2 domain, eIF4G, and translation but the
results do not agree with the observed in vivo translation rates that I have observed. It is
known that PAB1 is involved in various aspects of mRNA transport (Brune C, et al
2005), mRNA biogenesis (Dunn EF, et al 2005), and mRNA deadenylation (Yao, et al
2007, Caponigro G and Parker R 1995), so differences in the observed in vivo translation
rates and in vitro translation rates could be due to pleiotropic effects associated with a
PAB1 domain deletion or variant. Analysis of PAB1 domains able to simulate translation
in Xenopus oocytes is difficult to compare side by side with the analysis of translation
rates in the domain deletions because different domains are examined. Specifically, the
domains deleted were much smaller than the domains used for the analysis of translation
stimulation. Additionally, the ability of a PAB1 domain capable of translation
stimulation determines if the domain is sufficient for translation, the deletion analysis
determines if the domain is necessary for translation. Despite these problems, when
analyzing the PAB1 domains capable of translation stimulation, PAB1 RRM1/2,1 am
able to conclude that the PAB1 RRM1 and PAB1 RRM2 domains are both necessary and
sufficient for translation. The domains of PAB1 unable to stimulate translation compared
to full length PAB1 were PAB1 RRM3/4 and PAB1 P/C. This indicates that the only
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domains sufficient for translation are PAB1 RRM1/2. Additionally, when analyzing a
deletion of the domains incapable of translation stimulation, I observed that in vivo
translation rates were unaffected, indicating that the PAB1 RRM3, PAB1 RRM4, PAB1
P, and PAB1 C domains are not necessary for translation.
One purpose o f this study was to determine the role of PAB1 in translation.
Based on these findings, deletions in PAB1 do not have a major role in translation. The
domain deletion with the largest decrease in translation rate was PAB1-ARRM1 (72%,
Figure 5, Table 4). Compared against defects in known translation factors, ts eIF3 (45%,
Figure 4, Table 3) and ts eIF4E (29%, Figure 4, Table 3) the PAB1 domain deletion with
the largest decrease in translation rate is still much higher than defects in known
translation factors. The rates for PAB1 domain deletions and variants (70-112%, Figure
5, Table 4) are more similar to translation rates observed in strains with defects in mRNA
degradation, except for cafl A. (45-78%, Figure 4, Table 3).
Based on the observation that PAB1 does not have a large role in translation,
combination of PAB1 domain deletions and variants with lesions in eIF3 and eIF4E
should not affect in vivo translation rates. The only PAB1 variant that significantly
lowered the in vivo translation rate in the ts eIF4E strain was PAB1-184 (14%, Figure 7,
Table 6) compared to the ts eIF4E strain alone (29%, Figure 7, Table 6). Since PAB1184 abrogates eIF4G contact (Otero et al., 1999) and eIF4G is responsible for contacting
additional translation factors (Neff and Sachs, 1999; Dominguez et al., 1999), then
combining a defect in eIF4E with PAB1-184 should decrease translation rates. In order
to show more definitively that the contact between eIF4G and PAB1 is causing the
decreased in vivo translation rate, another PAB1 variant known to decrease eIF4G
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binding could be analyzed. Such a variant is PAB1-180, which carries the mutation KE
to ER and diminishes in vitro cap-dependent, poly(A) dependent translation, and binding
to eIF4G (Otero, et al., 1999). The PAB1 variant PAB1-134 decreased the in vivo
translation rate in the ts eIF3 strain to 31% (Figure 6, Table 5), which is significantly
lower than the ts eIF3 strain alone (45%, Figure 6, Table 5). Flow PAB1-134 interacts
with the translation factor, eIF3, is unclear, but the observed results indicate that PAB1134 acts on translation through a different mechanism than PAB1-184.
Another reason for this study was to determine if CAF1 and CCR4 have roles in
translation and if those roles are similar. Since the role in deadenylation of CAF1 and
CCR4 appears to be different, it would follow that the role in translation would be
different as well. Based on these results it does appear that both CAF1 and CCR4 have
roles in translation (Figure 8, Table 7), with the role of CAF1 being more critical than
CCR4. Combining defects in eIF4E (cdc33-l) with a lesion in cafl or ccr4 showed that a
cafl deletion decreased translation rates (15%, Figure 8, Table 7) more than a ccr4
deletion (24%, Figure 8, Table 7). These last observations support the hypothesis that
CAF1 has a greater role in translation than CCR4, and that the two proteins act through
different mechanisms. Furthermore, a PAB1-184 variant increased the in vivo translation
rate in a cafl A strain to 50% of wild type (Figure 8, Table 7), whereas a ccr4A strain
PAB1-184 lowered the rate to 38% of wild type (Figure 8, Table 7). This last
observation indicates that deleting ccr4 caused a similar decrease in translation as did a
cdc33-l allele, since the double mutant, cdc33-l PAB1-184 (14%) showed a lower
translation rate compared to the cdc33-l allele alone (29%, Figure 7, Table 6). How
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CCR4 and CAF1 function in translation is unclear at this time. What is clear is that both
CCR4 and CAF1 do have a role in translation and that role is different from one another.
Analysis of additional strains could provide the necessary insight to make a more
conclusive summary of this work. As mentioned in the discussion PAB1-180 showed
reduced in vitro contact between eIF4G and PAB1. If PAB1-180 shows a lowered in
vivo translation rate, similar to PAB1-184, when combined with a cdc33-l allele then the
hypothesis that decreasing contact between PAB1 and eIF4G is the reason for the
decreased cdc33-l PAB1-184 translation rate would be supported. Additionally,
combining PAB1-180 with PAB1-184 could be analyzed and would also support the
stated hypothesis if a decreased translation rate is observed. Correspondingly, combining
the PAB1-180 and PAB1-180, 184 variants with lesions in ccr4 and cafl would provide
additional information about how CCR4 and CAF1 function in translation.
The PAB1 variants, PAB1-134 and PAB1-184, represent substitutions of yeast
residues with the homologous human residues in the RRM2 domain. These variants have
provided some additional insight into how PAB1 functions in translation and substitution
of additional domains would provide additional information into how PAB1 functions in
translation. Analysis of a human substitution of PAB1 RRM3 has been done (Figure 5,
Table 4), but since no other domain substitutions were available for analysis at the time,
proper comparisons were not available to determine the significance of the decreased in
vivo translation rate for PABl-hRRM3. If the remaining domains were to be analyzed,
we could obtain more information about how the PAB1 domains are involved in
translation. For example, the PAB1-ARRM3 domain deletion did not show a large
decrease in translation, but the PABl-hRRM3 variant did show a larger decrease in
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translation. If PABl-hRRMl shows a large decrease in translation, then the PAB1hRRM3 decrease is probably a general effect due to changing the yeast domain with the
human domain. If PABl-hRRMl does not show a large decrease for the in vivo
translation rate, then we would hypothesize that the PAB1 RRM3 domain does in fact
play a role in translation, and the next step would be to make smaller substitutions in
RRM3. Obviously, additional work is needed to make more definitive conclusions, and
the work reported thus far has provided some observations that could be investigated
further.
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CHAPTER II

C 0X 17 DEADENYLATION RATES IN PAB1 VARIANTS

Introduction
Proper and appropriate gene expression is essential for all biological organisms.
Regulation of gene expression is necessary for many biological cues, such as:
embryological development, metabolic changes, cell cycle stages, and viral infection.
Gene expression can be controlled at many levels, ranging from transcriptional start
signals, mRNA degradation, and post-translational modifications. Because the longer a
mRNA transcript persists, the more protein can be translated from the transcript, and
conversely, the shorter a mRNA half-life is the less protein can be produced from the
corresponding mRNA transcript, one area of particular interest is gene regulation at the
level of mRNA degradation.
In Saccharomyces cerevisiae, a mature mRNA consists of a 3’ poly(A) tail,
approximately, 90-110 adenines in length, a m7Gppp cap at the 5’ ribonucleotide, and all
introns spliced from the mRNA body. Degradation of the mRNA begins with
deadenylation of the poly(A) tail by the PAN2/3 complex, which exonucleolytically
digests approximately 20 adenines (A ’s). T he C C R 4-N O T com plex th en digests the
poly(A) tail to a length of 8-12 adenines (Tucker et al., 2001). At this length the poly(A)
binding protein (PAB1) cannot efficiently bind the poly(A) tail, thus signaling decapping
(Coller et al., 1998; Sachs et al., 1987). The 5’ m7Gppp cap structure is cleaved through
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numerous proteins, such as DCP1/2, DHH1, EDC1, EDC2, LSM1-7, and PAT1
(Dunckley and Parker, 1999; Bouveret et al., 2000; Schwartz et al., 2003; Bonnerot et al.,
2000). Decapping allows for degradation of the mRNA body 5’ to 3’ by XRN1
(Muhlrad et al., 1994). Additionally, degradation by the exosome can occur in the 3’ to
5’ direction (Anderson and Parker, 1998; Mitchell et al., 1997).
As mentioned in the general introduction, several observations indicate that
deadenylation is the first and rate limiting step of mRNA degradation. Briefly, elements
in the UTR of mRNA that promote rapid degradation also promote accelerated
deadenylation rates (Decker and Parker, 1993; LaGrandeur and Parker, 1999; Caponigro
and Parker, 1996), and deadenylation rates of stable transcripts are much slower than
transcripts that degrade rapidly (Decker and Parker, 1993; LaGrandeur and Parker, 1999).
Since deadenylation is the first and rate limiting step of mRNA degradation,
understanding how deadenylation occurs is crucial to understanding how differential
mRNA degradation occurs.
The PUF family of proteins, as mentioned in the general introduction, is a group
of proteins responsible for translational repression and accelerating deadenylation of the
target transcript. It has been shown that PUF3 accelerates deadenylation of COX17
(Olivas and Parker, 2000). One approach to determining how deadenylation is
accelerated or decelerated is to investigate the mechanism that PUF3 accelerates
deadenylation.
Two models can explain how PUF3 accelerates mRNA deadenylation. The first
is a simple recruitment model. It has been shown that the PUF consensus sequence in the
5’ or 3’ UTR is capable of shortening the half life of an mRNA (Olivas and Parker, 2000;
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Graber, 2003). These flanking sequences bind proteins, such as PUF proteins, which in
turn bind mRNA degradation proteins, such as the CCR4-NOT complex (Figure 2A),
thus bringing the target mRNA into closer proximity to the degradation proteins. It has
been shown that PUF5 is capable of contacting CAF1 (Goldstrohm et al., 2006), which
contacts the major cytoplasmic deadenylase, CCR4. This observation provides support
for the recruitment model. The second model involves rearrangement of the mRNP
structure. The mRNP complex is composed of many proteins, but the core complex
consists of a mature mRNA, the cap binding protein, eIF4E, the poly(A) binding protein,
PAB1, and eIF4G, a bridging protein between eIF4E and PAB1. Through contact with
eIF4E, eIF4G, or PAB1 the PUF proteins could perturb the mRNP structure, allowing
mRNA degradation proteins access to the mRNA transcript (Figure 2B). Support for the
mRNP disruption model is shown through PUF3 and PUF5 co-immunoprecipitation of
eIF4E (Y. Chiang, personal communication). This suggests that PUF3 and PUF5 contact
the mRNP complex through eIF4E. The two models are not mutually exclusive,
however. It is possible PUF proteins could simultaneously recruit mRNA degradation
components and destabilize the mRNP complex (Figure 2C).
The role of eIF4E in deadenylation is not completely understood, but several
observations suggest it has an inhibitory role and interacts with PAB1. A cdc33-I allele,
encoding a temperature sensitive eIF4E protein, defective in cap binding (Altmann and
Trachsel, 1989), displayed an accelerated deadenylation rate for GAL1 (T. Ohn, personal
communication) and PGK1 (Schwartz and Parker, 1999), but not MFA2 (Schwartz and
Parker, 1999), suggesting that eIF4E has an inhibitory effect on deadenylation of
transcripts with an average to long half-life. Furthermore, deletion of PAB1 RRM1 and
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PAB1 P domains, the two domains of PAB1 that showed the greatest defects in
deadenylation and are responsible for circularization of PAB1 (Yao et al., 2007),
displayed accelerated deadenylation of GAL1 with a defect in eIF4E (T. Ohn, personal
communication). Formation of the circular PAB1 promotes deadenylation, so this last
observation suggests that eIF4E has a role in the circularization of PAB1. PAB1 is in
close proximity to eIF4E and we have shown that PAB1 co-immunoprecipitates eIF4E
(Y. Chiang, personal communication). One hypothesis is that PUF3 interacts with eIF4E
to disrupt PAB1 poly(A) binding by promoting the circularization of PAB1. By
understanding the role of PAB 1 in deadenylation we hope to understand how the mRNP
structure is involved in deadenylation.
In order to determine the role of PAB 1 in the differential degradation of a mRNA
transcript, deadenylation rates have been determined of an unstable mRNA and a mRNA
with an average half-life. Two mRNA suitable for comparison in the PAB1 variants are,
MFA2 which displayed a half-life of 3.5 minutes (Schwartz and Parker, 1999) and is
relatively fast, and GAL1 which has a mRNA half-life of 10 minutes (Cui and Denis,
2003) and is a rate more similar to the average mRNA half-life. If one PAB1 variant had
an effect on MFA2 that did not occur in GAL1, then the conclusion would be that the
particular PAB1 domain has a role in differential deadenylation. However, all PAB1
variants had the same effect on GAL1 and MFA2 (Yao et al., 2007), indicating that PAB1
does have a role in deadenylation, but that role may be a general role for transcripts with
an average and a fast deadenylation rate. If, in fact, PAB1 does have a general role in
mRNA deadenylation, then the deadenylation rate for the PAB 1 variants should be
similar for all transcripts. COX17 encodes an mRNA with a relatively fast half-life
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(Olivas and Parker, 2000), and a fast deadenylation rate (Olivas and Parker, 2000), so it
would be expected that C O Xl7 would behave similar to MFA2. Since, it is known that
the mRNA binding protein, PUF3, accelerates deadenylation of COX17 mRNA (Olivas
and Parker, 2000), analysis of the deadenylation rate of COXl 7 in each of the PAB1
variants would provide insight into the mechanism whereby PUF3 accelerates
deadenylation.
In this work I have analyzed the deadenylation rate of COXl 7 in PAB1 variants
containing a deletion for each of the domains, and have shown that PAB1-ARRM1
blocked deadenylation of COXl 7 and PAB1-A.P displayed a more similar deadenylation
pattern to wild-type. Previously, PAB1-ARRM1 and PABl-kP displayed a slower
deadenylation rate for both MFA2 and GALI (Yao, et al., 2007). The observation that
deadenylation rates for COXl 7 are different compared to MFA2 and GALI in the PAB1
variants indicates that PAB1 has a role in deadenylation that is different for a mRNA that
is dependent on PUF3 for proper deadenylation.
Materials and Methods
Strains and Plasmids Used
Strains and plasmids are listed in Tables 1 and 2.
Oligonucleotides Used
Table 8
Probe Name
COX17/dn
COX17/3' end
SCR1 probe250

Sequence of Probes Used for Northern Analysis
Sequence
5'

GCCATAACCCTTCATGCACTC

5' GGTTGTCGGCAGACTGTCAG
5' ATCCCGGCCGCCTCCATCAC
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Growth Conditions and Pulse-Chase
All strains were grown in 0.67% yeast nitrogen base without amino acids, and
amino acids as required (synthetic medium) containing 2% raffinose until exponential
growth phase was reached. Leucine was omitted from synthetic medium (leu- medium)
to ensure the presence of pRP1007. Cells were then resuspended in five mL of leumedium containing 2% raffinose. One mL of 25% galactose was added to induce
expression of the GAL10 promoter. Twenty minutes after induction, one mL of 50%
glucose was added, and one mL aliquots were removed and quick frozen in dry ice at the
designated time points.
RNA Analysis
RNA isolation. The hot phenol method was used to isolate total RNA. 500 pL of
TES (10 mM Tris pH 7.5, 10 mM EDTA, 0.5% SDS) and 500 pL of phenol were added
to frozen cells. Following a 65°C incubation with frequent vortexing, the mixture was
spun, and the aqueous layer removed. The aqueous layer was then cleared of protein and
lipids with a phenol wash, followed by a chloroform wash. RNA was then precipitated
with 100% ethanol and 1/10 volume 3M NaOAc pH 5.3. The pellet was washed in 70%
ethanol, dried and resuspended in 50 pL of DEPC treated water.
RnaseH digestion and analysis. 12-30 pg of RNA was incubated with the
COX17/dn probe at 75°C for ten minutes, and then one hour at 30 °C. An additional
sample was also hybridized to a DNA oligo-thymidine (dT), in addition to the COX17/dn
probe. The dT hybridizes to the poly(A) and RNaseH digestion removes the poly(A) tail
and also cleaves at the COX17/dn site. The dT sample allows for visualization of the
fully deadenylated fragment following Northern analysis. One U RNaseH was added
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with RNaseH buffer (40mM Tris pH 7.5, 20mM MgCh, lOOmM NaCl, 2mM DTT, 60
pg/mL BSA) and allowed to digest at 30 °C for one hour. Two hundred and eighty pL
stop buffer was added (0.04 mg/mL tRNA, 300mM NaOAc, 20mM EDTA), and the
digested RNA was cleared of protein with phenohchloroform (1:1), and chloroform. The
RNA was precipitated with 100% ethanol and washed with 70% ethanol. RNA was then
separated on a 6% urea polyacrylamide gel, transferred to a nitrocellulose membrane and
probed using a [32P]-labeled COXl7/3’ end probe. Phophor imaging screen - K was used
to detect radio-labeled COXl 7 mRNA, the screens were scanned using the Bio-Rad
Molecular Imager - FX, and Quantity One software was used to print and manipulate the
images. Following detection of COXl 7, membranes were re-probed for small
cytoplasmic RNA 1 (SCR1). SCR1 is an abundant RNA with a very long half-life and no
poly(A) tail, making it a very useful loading control.
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Results

COXl 7 Behaves as Expected in a PAB1 Wild Type Strain and in a PAB1 Wild Type
Strain Containing a PUF3 Deletion
Since it is known that COXl 7 mRNA requires PUF3 for deadenylation of the
poly(A) tail (Olivas and Parker, 2000; Jackson et al., 2004; Houshmandi and Olivas,
2005), COXl 7 is a suitable mRNA for determining if PAB 1 is involved in PUF3mediated deadenylation. COXl 7 expression was driven by a GAL 10 promoter allowing
for synthesis o f COXl 7 mRNA upon addition of galactose (pulse) to exponentially
growing cells. Deadenylation of the COXl 7 mRNA followed after transcription of
COXl 7 mRNA was shut-off with glucose (chase). Deadenylation of COXl 7 was
analyzed in PAB1 domain deletions with wild-type PUF3 and a puf3 deletion. In the
wild-type PAB1 PUF3 strain, the COXl 7 poly(A) tail reached the oligo(A) form by five
minutes, and by fifteen minutes there was almost no transcript remaining (Figure 9A),
indicating that mRNA decapping and degradation had taken place. In contrast, in the
Xpuf3 background, which is known to display slowed deadenylation of the COXl 7
poly(A) tail (Olivas and Parker, 2000), deadenylation was slowed and the oligo(A) form
did not appear until 15 to 20 minutes (Figure 9C). Furthermore, in the PUF3 background,
at 30 minutes there is still a significant amount of COXl 7 mRNA present (Figure 9C),
which is indicative of slowed decapping, as previously observed (Olivas and Parker,
2000). These results reflect what has been previously shown about the effect of PUF3 on
COXl 7 (Olivas and Parker, 2000), and indicate that this analysis is suitable for
determining any PAB1 effects on COXl 7 deadenylation.

60

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

PAB1-WT
Apuf3

PUF3

A
dT

0

2

dT 0

5 10 15 20 30

2

5 10 15 20 30

C0X17
60A-

70A-

0A-

OA-

jg

A *

SCR1
B
£30

£ 30-

<10

<

0

5

10

15

20

25

30

35

10-

0

5

10

15

20

25

30

35

Time (min)

Time (min)

Figure 9 - Deadenylation assay of COXl 7 in wild-type PAB1 background. One sample
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription
shut off as depicted in panel A and panel C, respectively. (C) Apu/3.
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The PAB1 RRM1 Domain is Necessary for Deadenylation of COXl 7

Previous analysis has shown that deletion of the RRM1 domain in PAB1 slows
deadenylation of GALI and MFA2 mRNA but does not stop it completely (Yao et al.,
2007). If PUF3 does not specifically interact with the mRNP complex or PAB1, then
COXl 7 should behave the same as GALI and MFA2 in respect to an RRM1 deletion.
Moreover, if the deadenylation mechanism that PAB1 RRM1 works through is the same
for all mRNA, then MFA2 and COXl 7 should show similar deadenylation rates relative
to the wild-type PAB1. In a strain with a PAB1 RRM1 deletion, COXl 7 showed
extremely slow deadenylation (Figures 10A, C), in both wild type PUF3 and the puf3
deletion, COXl 7 poly(A) tail lengths were only marginally shorter in the 30 minute time
point compared with the zero minute time point. Compared to the deadenylation rate of
GALI and MFA2 (Figures 11, 12 - Yao et al., 2007), the PAB1-ARRM1 variant showed a
block in deadenylation more severe for COXl 7. This observation indicates that the
RRM1 domain of PAB 1 is absolutely required for deadenylation of the COXl 7 poly(A)
tail.
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Figure 10 - Deadenylation assay of COXl 7 in a PAB1-ARRM1 background. One sample
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription
shut off as depicted in panel A and panel C, respectively. (C) Apuf3. experiments.
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Figure 11 - Summary of GAL1 deadenylation rates conducted by Gang Yao, and
published as supplementary figures (Yao et al., 2007). PAB1-ARRM1 and PAB1-AP
deadenylation rates are much slower compared to wild-type and PAB1-ARRM3.
Deadenylation in PAB1-ARRM1 and PAB1-AP is blocked as is shown in a Acer4
background.
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Figure 12 - Summary of MFA2 deadenylation rates conducted by Gang Yao, and
published as supplementary figures (Yao et al., 2007). PAB1-ARRM1 and PAB1-AP
deadenylation rates are much slower compared to wild-type and PAB1-ARRM3.
Deadenylation in PAB1-ARRM1 and PAB1-AP is blocked as is shown in a Acer4
background.
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The Effect of PAB1 RRM2 on COX17

Previous analysis of PAB1-ARRM2 showed a slower deadenylation rate for both
MFA2 and GAL1 (Yao et al., 2007). The deadenylation rate of MFA2 and GAL I in
PAB1-ARRM2 was not as slow as observed for the two domain deletions resulting in the
slowest deadenylation rates, PAB1-ARRM1 and PAB1-AP, but was slower compared to
wild-type. My analysis of COX17 in a PAB1-ARRM2 background also showed a slower
deadenylation rate with wild-type PUF3 and a lesion inpuf3 (Figures 13 A, B, C, D), but
not as slow as in a PAB1-ARRM1 background (Figure 10A, B). It has been shown that
deletion of the RRM2 domain in PAB1 causes destabilization of the CCR4-NOT
complex, resulting in about a four-fold reduction in CCR4 abundance in the cell (Yao et
al., 2007). Since the CCR4-NOT complex is responsible for the majority of
deadenylation of mRNA (Tucker et al., 2001), this explains the slower deadenylation
rates for GAL1, MFA2, and COX17 in a PAB1-ARRM2 background compared to wildtype (Yao et al., 2007; Figures 9A, B). Additionally, this suggests that the PAB1 RRM2
domain plays the same role in deadenylation for mRNA dependent and independent on
PUF3 for accelerating deadenylation.
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Figure 13 - Deadenylation assay of COX17 in a PAB1-ARRM2 background. One sample
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription
shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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The Effect of PAB1 RRM3 on COX17

Deletion of the RRM3 domain in PAB1 was shown to accelerate the
deadenylation rates of MFA2 and GAL1 mRNA (Yao et al., 2007). The COX17 transcript
in PAB1-ARRM3 with wild-type PUF3 showed that the poly(A) tail was completely
deadenylated by five minutes (Figure 14A), which in wild-type PAB1, COX17 mRNA
became nearly completely deadenylated by this time point. Although COX17 poly(A)
tail length at the five minute time point is the same for both wild-type PAB1 and PAB1&RRM3, the poly(A) tail length at the zero minute time point is much shorter in the
PAB1-IS.RRM3 background (-12 A ’s, Figure 14B) compared to the wild-type PAB1
background (-28 A ’s, Figure 9B). In addition, COX17 mRNA is nearly gone by ten
minutes in an RRM3 deletion background in contrast to 15 minutes for wild-type. These
results suggest that deleting the RRM3 domain in PAB1 accelerates deadenylation in a
PUF3 background.
In the Apuf3 background, the PAB1 RRM3 deletion also accelerated COX17
deadenylation (Figure 14C). The COX17 mRNA does not completely deadenylate in a
puf3 deletion with wild-type PAB1 (Figure 9C) whereas a fully deadenylated COX17
mRNA was observed at the fifteen minute time point in a PAB1-A.RRM3 background,
despite the absence ofpuf3 (Figure 14C). This indicates that the mechanism whereby
PAB1-ARRM3 accelerates deadenylation is a general mechanism that works on mRNA
independent and dependent on PUF3.
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Figure 14 - Deadenylation assay of COX17 in a PAB1-ARRM3 background. One sample
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription
shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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The Effect of PAB1 RR.M4 on COX17

Previous analysis of PAB1-ARRM4 showed no change in the deadenylation of
MFA2 and GAL1 mRNA compared to wild-type (Yao et al., 2007). Analysis of COX17
mRNA showed a poly(A) tail length of zero A ’s by five minutes in a PAB1-ARRM4
background (Figure 15A), which is similar to wild-type (Figure 9A). The double mutant,
PAB1-ARRM4 Apuf3, displayed a slightly slower deadenylation rate compared to Apuf3
alone (Figures 15D and 9D). In the Apu/3 alone, the poly(A) tail length of COX17 is
deadenylated to a length of 8-10 A’s by fifteen minutes and remains at that length for the
remaining time points (Figure 9C). In comparison, the double mutant, PAB1-ARRM4
Apu/3, showed the COX17 transcript deadenylated to the same length as the Apu/3 alone,
8-10 A’s, by twenty minutes (Figure 15C). These observations suggest that the RRM4
domain o f PAB1 is at least partially responsible for proper deadenylation of PUF3
dependent transcripts when PUF3 is absent.
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Figure 15 - Deadenylation assay of COX17 in a PAB1-ARRM4 background. One sample
was hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated
species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type
PUF3. (B and D) Average poly(A) tail length as a function of time after transcription
shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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PAB1 P Domain is not Necessary for Deadenylation of COX17

In a deletion of the P domain of PAB1, GAL1 and MFA2 showed an extreme
deficiency in deadenylation (Figures 11, 12 - Yao et al., 2007). In contrast with GAL1
and MFA2 deadenylation data, the PAB1-AP variant showed almost complete
deadenylation of COX17 by ten minutes and no visible mRNA by fifteen minutes (Figure
16A). The PAB1-AP puf3A strain showed a block in deadenylation more severe than the
PAB1 puf3A strain (Figure 16C), after 30 minutes deadenylation remained completely
blocked in the PAB1-AP puf3A strain. This observation indicates that the block in
deadenylation observed by a PAB1 P deletion is bypassed by PUF3, and that deletion of
both PUF3 and the PAB1 P domain severely impairs deadenylation.
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Figure 16 - Deadenylation assay of COX17 in a PAB1-&P background. One sample was
hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated species.
Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type PUF3. (B
and D) Average poly(A) tail length as a function o f time after transcription shut off as
depicted in panel A and panel C, respectively. (C) Apuf3.
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The Effect of PAB1 C on COX17

Analysis of MFA2 and GAL1 in PAB1-AC showed a slight decrease in the rate of
deadenylation (Yao et al., 2007). The translation termination factor eRF3 and PAN2/3
complex are two proteins that contact the C terminal domain of PAB1 (Mangus et al.,
1998; Hosoda et al., 2003; Kobayashi et al., 2004). Since eRF3 and deadenylation has
been shown to be linked (Hosoda et al., 2003; Kobayashi et al., 2004) and PAN2 is a
known deadenylase, it is likely that the role of the C terminal domain in PAB1 is a
general one that affects all or most mRNA. In the PAB1-AC background the
deadenylation rate of COX17 is slightly slower (Figure 17A) compared to wild-type
PAB1 (Figure 9A) and when puf3 is deleted in the FAB 1-AC variant (Figure 17C) the
deadenylation rate is much slower compared to the wild-type PAB1 Apuf3 strain (Figure
9C). By ten minutes the COX17 poly(A) tail length has reached zero A ’s in wild-type
PAB1 (Figure 9A) and in the PAB1-AC variant at ten minutes there is still COX17 mRNA
present (Figure 17A), indicating that deletion of the C domain in PAB1 slows
deadenylation slightly. The COX17 poly(A) tail length in the double mutant, PAB1-AC
Apu/3, was deadenylated to a length of approximately 20 A’s by the fifteen minute time
point (Figures 17C, D) and remained at a length of approximately 20A’s until the last
time point was taken at thirty minutes, which is twice as long as the terminal poly(A) tail
length of COX17 in the wild-type PAB1 Apu/3 strain (Figure 9C, D). This indicates that
COX17 mRNA shows a similar decrease in the deadenylation rate as MFA2 and GAL1,
which suggests that the C terminal domain of PAB1 plays a PUF3-independent role in
deadenylation.
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Figure 17 - Deadenylation assay of COX17 in PAB1-AC background. One sample was
hybridized to an oligo-thymidine (dT) in order to identify the fully deadenylated species.
Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A) Wild-type PUF3. (B
and D) Average poly(A) tail length as a function of time after transcription shut off as
depicted in panel A and panel C, respectively. (C) Apuf3.
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Decapping of COX17 is not Affected by PAB1 Deletions
In the major mRNA degradation pathway, deadenylation is the initial step,
followed by decapping and degradation of the mRNA body. Since decapping can be
inhibited by PAB1 (Morrissey et al., 1999; Caponigro and Parker, 1995), it is possible
that mutations in PAB1 have an effect on decapping and eventual degradation of the
mRNA. If a decapping defect is present then two events could occur. First, mRNA
degradation could be blocked despite deadenylation of the poly(A) tail. Second, mRNA
degradation could occur independently of deadenylation. The first event would be
observed if COX17 mRNA does not degrade following deadenylation. A wild type PUF3
background accelerates COX17 deadenylation in the following PAB1 domain deletions:
PAB1-ARRM2, PAB1-ARRM3, PAB1-ARRM4, PAB1-AP, and PAB1-AC (Figures 13A,
14A, 15A, 16A, 17A), and since COX17 mRNA has degraded following deadenylation,
none of these PAB1 domain deletions caused a defect in decapping. Furthermore, when
COX17 deadenylation is blocked as observed in PAB1-ARRM1 we do not see any COX17
mRNA being degraded (Figure 1OA). This last observation does not support the second
event, that mRNA degradation could occur independently of deadenylation.
A puf3 deletion is known to block COX17 mRNA decapping. This can be
observed in Figure 9C in which COX17 mRNA does not become degraded after the oligo
(A) form o f COX17 is reached at about 15 minutes. None of the PAB1 variants that I
analyzed bypassed this affect of pu/3A on the decapping of COX17. These observations
indicate that the analyzed PAB1 domain deletions do have a role in deadenylation but not
in decapping.

76

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The decapping step has been shown to occur in discrete locations in the
cytoplasm, labeled P bodies (Sheth and Parker, 2003). PAB1 and the deadenylases have
been shown to localize to the cytoplasm (Sheth and Parker, 2003), suggesting that
deadenylation occurs in the cytoplasm and the deadenylated mRNA then moves to P
bodies where decapping and further degradation occurs. Since deadenylation occurs in a
puf3 deletion but degradation does not occur (Figures 9C, 10C, 13-17C) it is likely that
PUF3 has a role in the degradation and possibly decapping of COX17 mRNA. Because
PUF3 is localized in the cytoplasm (Sheth and Parker, 2003), while PUF3 itself does not
localize to P bodies (Sheth and Parker, 2003) it is possible that PUF3 is involved in the
transport of COX17 mRNA from the cytoplasm to P bodies. This could be easily
observed by examining the localization of COX17 mRNA. A GFP-MS2 fusion has been
shown allow visualization of an mRNA containing a MS2 binding site within the
transcript (Sheth and Parker, 2003). Determination of the localization of COX17 in
PUF3 and Apuf3 strains could be accomplished by examining if PUF3 has a role in the
transportation of COX17-MS2 from the cytoplasm to P bodies.
The Effect of eIF4E on COX17
A defect in the cap binding protein, eIF4E, was shown to accelerate the
deadenylation rate of the stable mRNA, PGK1, which has an average half-life of 17
minutes in a wild-type background (Schwartz and Parker, 1999). The unstable mRNA,
MFA2, which has a half-life of 3.5 minutes, did not show an accelerated deadenylation
rate when a defect in eIF4E was present (Schwartz and Parker, 1999). The first
observation indicates that wild-type eIF4E slows deadenylation by some unknown
mechanism. The second observation could be explained by three possibilities. First, the
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deadenylation mechanism that eIF4E acts on does not affect MFA2. The second
possibility is that the deadenylation rate of MFA2 is so fast that the deadenylation
mechanism that eIF4E acts on does not affect MFA2 or any mRNA with a fast
deadenylation rate. Third, the defect in eIF4E does accelerate the deadenylation rate, but
the change is undetectable by this assay.
Our previous results showed that PUF3 is capable of co-immunoprecipitation of
eIF4E (Y.C. Chiang, personal communication). If PUF3 makes contact with eIF4E or
another translation initiation factor to mediate deadenylation then a defect in eIF4E
should show a change in the deadenylation rate of COX17. Since it has been shown that
a defect in eIF4E is capable of accelerating the rate of deadenylation for GAL1 and PGK1
(T. Ohn, personal communication; Schwartz and Parker, 1999), we would expect that
deadenylation of COX17 would be accelerated as well. In order to test if the eIF4E
defect affects deadenylation of COX17 ,1 analyzed the COX17 deadenylation rate in a
strain carrying the cdc23-l allele, which encodes a temperature sensitive eIF4E protein.
The cdc33-l allele, at 37°C, did not cause a significant increase in the deadenylation rate
compared to the wild-type strain at 37°C (Figure 18A, 19A), and both wild-type and
cdc33-l strains showed oligo-adenylated poly(A) tail length by two minutes and the
COX17 mRNA was gone by five minutes (Figure 18A, 19A). This observation is similar
to what was observed for MFA2 (Schwartz and Parker, 1999) and the same three
possibilities apply. It is possible that the mechanism whereby eIF4E accelerates
deadenylation does not work on COX17. However, since both COX17 and MFA2 are
both very unstable mRNA, it is likely that the mechanism that eIF4E works through is
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just not apparent for these two mRNA, as the deadenylation rate is already so fast that a
defect in eIF4E would not accelerate it even further.
If the mechanism whereby eIF4E works to accelerate deadenylation is a general
mechanism affecting all mRNA, then deadenylation of COX17 in a puf3 deletion
background should be accelerated as well. Analysis of the double mutant, cdc33-l
Apuf3, showed deadenylation of COX17 stop at ten minutes (Figures 19B, D), which is
the same time point when deadenylation of COX17 stopped in the strain carrying the
lesion in puf3 alone at 37°C (Figure 18B, D). The difference in poly(A) tail length may
be due to decapping occurring much faster due to the defect in eIF4E, which has been
observed previously to inhibit the decapping reaction (Schwartz and Parker, 1999;
Schwartz et al., 2003). A defect in eIF4E does appear to affect the final length of the
COX17 poly(A) tail ifpuf3 is absent (Figures 18B, 18D, 19B, 19D), so it is likely that
eIF4E does affect COX17 mRNA. However, these observations indicate that PUF3 is
required to accelerate deadenylation of COX17, despite the defect in eIF4E (Figures 19A,
B, C, D). This indicates that the mechanism that PUF3 acts through, is downstream of
the mechanism that eIF4E works through.
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Figure 18 - Deadenylation of COX17 at 37°C. Assay was conducted at 37°C, as a control
for the cdc33-l allele. One sample was hybridized to an oligo-thymidine (dT) in order to
identify the fully deadenylated species. Small cytoplasmic RNA 1 (SCR1) is used as a
loading control. (A) Wild-type PUF3. (B and D) Average poly(A) tail length as a
function of time after transcription shut off as depicted in panel A and panel C,
respectively. (C) tspuf3.
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Figure 19 - Deadenylation assay of COX17 in PAB1-WTcdc33-l background. Assay
was conducted at 37°C, the non-permissive temperature for the cdc33-l allele. One
sample was hybridized to an oligo-thymidine (dT) in order to identify the fully
deadenylated species. Small cytoplasmic RNA 1 (SCR1) is used as a loading control. (A)
Wild-type PUF3. (B and D) Average poly(A) tail length as a function of time after
transcription shut off as depicted in panel A and panel C, respectively. (C) Apuf3.
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Strain
319/504
319/505
319/506
319/507
319/508
319/510
319/509
319/504 37°C
1881/504
1738/504
1738/505
1738/506
1738/507
1738/508
1738/510
17.8/509
1738/504 37°C
1777/504

Relevant Genotype
PAB1-WT
PAB1-ARRM1
PAB1-ARRM2
PAB1-ARRM3
PAB1-ARRM4
PAB1-AC
PAB1-AP
PAB1-WT 37°C
cdc33-1
PAB1-WT Apuf3
PAB1-ARRM1 Apuf3
PAB1-ARRM2 Apuf3
PAB1-ARRM3 Apuf3
PAB1-ARRM4 Apuf3
PAB1-AC Apuf3
PAB1-AP Apuf3
PAB1-WT Apuf3 37°C
cdc33-1 Apuf3

Rate (A's/min)
5.4
0.5
1.4
3.5
5.3
3.1
5.7
4.7
1.7
0.9
0.4
0.6
0.5
1
0.6
0.7
1.3
0.4

t for 0 A s
5
>30
20-30
5
10
10
5
5
5
30
>30
>30
15
20
>30
>30
10
>30

SEM
0.3
0
0.3
0.6
1
0.2
0.3
0.4
0.4
0.2
0
0.1
0.1
0
0
0
0.1
0.1

Total Samples
4
4
2
2
3
5
3
3
2
4
3
2
2
3
4
3
2
2

Table 9 - Summary table o f COX17 deadenylation rates. SEM is the standard error of
the mean of the rate, calculated by dividing the standard deviation by the square root of
the total number of samples. For strains with a very fast deadenylation rate it was
difficult to obtain a precise measure of the true deadenylation rate. In order to analyze
the deadenylation rate, a qualitative approach was used. The qualitative approach that I
used was to describe at what time point the COX17 poly(A) tail was fully deadenylated as
indicated by “t for 0 A ’s”.
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Discussion
This data provides three observations supporting the model that PUF3 interacts
with components o f the mRNP complex for proper deadenylation. First, the RRM1
domain of PAB1 is required for deadenylation of COX17 (Yao et al., 2007). Second,
PUF3 is able to bypass the requirement of the P domain in PAB1, which was shown to be
required for deadenylation of MFA2 and GAL1 (Yao et al., 2007). Third, we have also
shown that PUF3 co-immunoprecipitates multiple components of the CCR4-NOT
complex (Y. Chiang, personal communication), and COX17 requires CAF1, CCR4, and
PAN2 for deadenylation (Tucker et al., 2002). These observations suggest that PUF3
works to simultaneously perturb the mRNP complex and recruit deadenylases.
Although this data shows an interaction between PAB1 and PUF3, the exact
mechanism whereby PUF3 communicates with PAB1 is still a mystery. Since PUF3 did
not co-immunoprecipitate PAB1 (data not shown), nor did apoly(A) sepharose pull
down identify PUF3 (G. Quigley, personal communication), it is likely that PUF3 makes
unknown proteins contacts which are responsible for PAB1 contacts. In Drosophila,
Pumilio contacts Nanos and Brat to repress hunchback mRNA (Edwards et al., 2001;
Wang et al., 2002; Wang et al., 2001; Edwards et al., 2003). This observation, supports
the model that PUF3 in Saccharomyces could function in a similar manner by contacting
additional proteins that are responsible for contacting PAB1.
Since eIF4E did co-immunoprecipitate with PUF3, it is possible that some sort of
communication between PUF3 and PAB1 is mediated through the cap-binding protein.
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In order to show that PUF3 does in fact contact eIF4E, the pull down would need to be
conducted in the presence of RNaseA to rule out RNA contacts. If the eIF4E and PUF3
contact is RNA independent then a yeast two-hybrid experiment, or an in vitro binding
experiment could be used to show that the two proteins do in fact interact. Additionally,
to show that eIF4E does act on PUF3 controlled mRNA, a mRNA with a slower
deadenylation rate would need to be used to show that a defect in eIF4E does in fact
accelerate deadenylation of a PUF3 controlled mRNA. CYT2 or TUF1 have recently
been shown to be controlled by PUF3 (Olivas W, poster #380, RNA meeting 2007).
These mRNA would be suitable candidates to show that a defect in eIF4E does accelerate
deadenylation of PUF3 controlled mRNA. Alternatively, a chimeric GAL1-COX17 3’
UTR could be used for further analysis. This could be used to show that the PUF3
consensus sequence is sufficient to accelerate deadenylation of a non-PUF3 controlled
mRNA. If the chimeric reporter has a slower deadenylation rate then we could analyze
the mRNA in a cdc33-l background, which could show more definitively that a defect in
eIF4E does or does not require PUF3 to accelerate deadenylation.
This work and previous work has shown that the various PAB1 domains each
play different roles in deadenylation. It is likely that since the RRM2, RRM3, and C
domains in PAB1 act on general mechanisms that they affect all mRNA, or at the very
least that they affect both PUF3-dependent and PUF3-independent transcripts. The P
domain in PAB1 is necessary for proper deadenylation of transcripts that do not require
PUF3. The requirement for this domain in COX17 deadenylation was bypassed by the
PUF3 protein to allow rapid deadenylation and degradation of the COX17 mRNA. PUF3
and the P domain function may act through a similar mechanism in the deadenylation of
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transcripts. This work has shown that the PAB1 RRM1 domain is absolutely necessary
for deadenylation of COX17, indicating that PUF3 somehow works through PAB1 RRM1
in some way to accelerate deadenylation. Although further work is necessary to
definitively prove that eIF4E requires PUF3 for proper deadenylation, these results
suggest that PUF3 works downstream of eIF4E in the deadenylation process.
This work provides support for the model that PUF3 does in fact work through the
mRNP complex to accomplish deadenylation of its target transcripts. Our studies and
those of others have also provided evidence that PUF proteins recruit deadenylases to the
target transcript, suggesting that PUF proteins both recruit and perturb the mRNP
complex to accomplish deadenylation and eventual degradation of the transcript.
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GENERAL DISCUSSION

In this work I have investigated the biological roles of the mRNP complex,
focusing specifically on the poly(A) binding protein (PAB1) and its role in mRNA
deadenylation. The two processes that I have examined are: the relationship of to mRNA
deadenylation and the role of PAB1 in controlling regulated mRNA deadenyaltion.
The in vivo translation analysis of PAB1 was conducted for two reasons. First, in
vivo translation rates were measured in each of the PAB1 variants to determine which, if
any of the domains have a role in translation in vivo. The second reason for this analysis
is to determine if any of the PAB1 domains have pleiotropic effects, specifically on
translation and deadenylation. It has been shown that translation and mRNA degradation
are linked (Schwartz and Parker, 1999), and it is also known that PAB1 plays a role in
both translation (Sachs and Deardorff, 1992; Otero et al., 1999; Gray et al., 2000) and
mRNA deadenylation (Tucker et al., 2002; Wilusz et al., 2001; Caponigro and Parker,
1995). Hence, a defect that a PAB1 variant may have on mRNA deadenylation could
also cause a defect in translation or a defect in translation could cause a defect in
deadenylation.
The first conclusion of the in vivo translation analysis is that individual domains
of PAB1 do not have a major role in translation. Because none of the PAB1 variants
displayed a decrease in translation rate as severe as defects in known translation initiation
components, such as eIF3 or eIF4E (Figure 4, Table 3), this analysis suggests that PAB1
has a minor role in translation. However, the minor role that PAB1 does play in
translation appears to be mediated by the RRM1 and RRM2 domains. Of the PAB1
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domain deletions, only deleting RRM1 and RRM2 showed a significant decrease in the
rate of in vivo translation (Figure 5, Table 4), suggesting that only two of the six domains
are involved in translation. Previous experiments support this observation. Analysis of
PAB1 domains capable of translational stimulation showed that only domains RRM1 and
RRM2 were sufficient to stimulate translation (Gray et al., 2000). Since PAB1 lethality
can be rescued by RRM1/2 but not other domains, these observations suggest that the
PAB1 translational role of RRM1/2 is important. But since individual deletions of PAB1
RRM1 and RRM2 had a minor effect on translation, it is likely that the PAB1 RRM1 and
RRM2 domains do not have direct roles in translation, and appear to support the function
o f additional factors.
Analysis of the PAB1 variants in combination with other factors indicates that
PAB1 RRM2 has roles in translation related to eIF4E and eIF3. eIF4E and eIF3 are
involved in different aspects of translation initiation, suggesting that PAB1 is involved in
different processes of translation. These observations do not indicate a definitive
mechanism for PAB1 involvement in translation but does indicate that PAB1 does in fact
play multiple roles. Additionally, this data confirms previous in vitro experiments which
indicate PAB1 RRM2 plays a key role in translation (Kessler and Sachs, 1998; Otero et
al., 1999).
My work provides additional evidence linking translation and deadenylation.
CAF1 involvement in deadenylation is known (Tucker et al., 2002), albeit, in a partially
separate role from the major deadenylase, CCR4 (Ohn et al., 2007). My analysis has
confirmed that CAF1 has a role in translation and that role is more important and
different from CCR4 (Figure 8, Table 7). The evidence suggesting that CAF1 and CCR4
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have separate roles in translation is supported by the observation that a lesion in cafl
caused a greater defect in translation combined with the PAB1-184 variant, whereas a
lesion in ccr4 caused a greater defect in translation when combined with the PAB1-134
variant (Figure 8). Because a deletion of cafl has a greater defect on translation with
PAB1-184, whereas a deletion of cc.r4 did not, it is likely that CAF1 is involved in the
mechanism that PAB1-184 participates in, whereas CCR4 is involved in a similar
mechanism as PAB1-134. PAB1-184 functions to aid eIF4G contact to PAB1 and in vitro
it blocks translation. PAB1-134 in contrast, destabilizes the mechanism of translation
initiation that eIF3 is involved in. This indicates that PAB1 is involved in translation and
that involvement requires many additional factors. Furthermore, because defects in
PAB1 alone do not cause major defects in translation, and a large decrease in translation
is observed when PAB1 variants are combined with other defects, this suggest that PAB1
may not have a direct role in translation. Instead, PAB1 may merely serve as a scaffold
for the translation initiation factors to assemble on. More specifically, the PAB1 RRM1
and RRM2 domains are the location for the translation initiation factors to bind.
In the second part of my thesis, I analyzed the effect of PAB 1 defects on on the
PUF3 regulated deadenylation of COX17. Transcriptional pulse-chase analysis of PAB 1
domain deletions, displayed a decreased deadenylation rate for GAL1, MFA2, and COX17
in PAB1-ARRM2 and PAB1-AC backgrounds (Yao et al., 2007; Figures 13A, B, 17A, B;
Table 9), whereas, aPABl-ARRM3 background displayed an accelerated deadenylation
rate (Yao et al., 2007; Figure 14A, B; Table 9). These observations suggest that PAB1
acts positively and negatively on deadenylation, multiple PAB1 domains are involved in
deadenylation, and these domains act through mechanisms that are similar for PUF3
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dependent and independent mRNA. The most severe deadenylation defect of GAL1 and
MFA2 was in PAB1-ARRM1 and PAB1-AP backgrounds (Figure 11, 12 - Yao et al.,
2007). These domains have also been shown to be important for PAB1 self association
(circular form) and formation of PAB1 multimers. More importantly, these self
associated PAB1 species bind poly(A) less efficiently than single, linear PAB1 (Yao et
al., 2007). This suggests that formation of circular PAB1 causes dissociation of PAB1
from the poly(A) tail, which stimulates deadenylation (Figure 20A). Because deletion of
the RRM1 domain caused the most severe deadenylation defect of GAL1, MFA2, and
COX17 (Figures 11, 12 - Yao et al., 2007; Figure 10A, B; Table 9) it is likely that this
domain is the most crucial for the PAB1 role in deadenylation. A likely model is that
PAB1 RRM1 is responsible for PAB1 dissociation and binding of poly(A). Since
roughly equivalent amounts of circular and linear PAB1 have been observed (Yao et al.,
2007), it is likely that the disassociated PAB1 (circular) and bound PAB1 (linear) are in
equilibrium. In order for rapid deadenylation to occur, some sort of stabilizing
mechanism is necessary to maintain the PAB1 circular form.
In addition to the PAB1 RRM1 domain, the P domain in PAB1 is also necessary
for formation of the PAB1 circular species. This suggests that the PAB1 P domain is
necessary for formation of circular PAB1, and therefore would be necessary for
deadenylation. It has been demonstrated that the PAB1 P domain is necessary for
deadenylation of GAL1 and MFA2 but not COX17 (Figures 11,12 - Yao et al., 2007;
Figure 16A, B; Table 9). Since PUF3 is involved in deadenylation of COX17, it is likely
that PUF3 bypasses the requirement of the PAB1 P domain. If the PAB1 P domain is
acting to promote formation of circular PAB1 then PUF3 must also promote formation of
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circular PAB1. Since is has not been show that PUF3 contacts PAB1 (G. Quigley,
personal communication; results not shown), it is likely that PUF3 contacts another
protein which is responsible for contacting and stabilizing the circular form of PAB1.
Several observations suggest that eIF4E and other TIFs are involved in preventing
formation of circular PAB1. The first observation is that eIF4E co-immunoprecipates
with PUF3. Second, PAB1-ARRM2 can still interact with TIFs (Y. Chiang, personal
communication). Since PAB1 RRM2 is known to contact eIF4G, which in turn binds
eIF4E, these results imply that the TIFs are making contact to other domains of PAB1,
such as to RRM1. Third, deleting the RRM1 domain reduces by two to three fold the
amount of eIF4G associated with PAB1, which suggests that eIF4E contacts PAB1
through contacts in addition to the RRM2 domain of PAB1. This suggests that PUF3
could contact PAB1 through eIF4E. Fourth, a defect in eIF4E caused accelerated
deadenylation o f GAL1 and PGK1 (Schwartz and Parker, 1999; T. Ohn, personal
communication). This suggests that the TIF complex blocks or slows deadenylation,
perhaps by inhibiting the formation of the circular PAB1. One model that incorporates
these observations is that eIF4G contacts PAB1 through the RRM1 domain to prevent
PAB1 from circularizing and dissociating from poly(A). In this model, dissociation of
PAB1 from poly(A) occurs through circularization of PAB1, which happens freely and is
the favored structure, but, eIF4G, or any TIFs, contact to PAB1 prevents circularization.
Through binding of the PAB1 P domain or PUF3 to eIF4E/eIF4G/eIF4A the connection
between PAB1 and the TIFs is broken or diminished, thus allowing for more circular
PAB1 and making the poly(A) to be more accessible to CCR4 (Figure 20B).
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Obviously, more work needs to be done to support this model. If TIFs are
responsible for inhibiting formation of circular PAB1, the amount of circular PAB1
should be higher in a cdc33-l background compared to wild-type. This could be shown
by comparing the relative abundance of the circular form in a cdc33-l background versus
a wild-type.
In order to prove the competition model, whereby the P domain of PAB1 or PUF3
competes with PAB1 RRM1 for TIF binding, three observations would need to be
confirmed. First, it must be shown that PUF3 contacts TIFs directly, which could be
done through in vitro binding assays. Second, it must be shown that addition of PUF3
disrupts or diminishes the TIF PAB1 contact. If the first observation is correct, then this
could be done by adding PUF3 to purified eIF4G and purified PAB1, and determining if
less eIF4G binds to PAB1. Third, contact between eIF4G and PAB1 must be completely
disrupted and shown that this contact has a role in formation of circular PAB1 and
accelerates deadenylation. Since PAB1-180 and PAB1-184 have been shown to contact
eIF4G (Otero et al., 1999), a combination of these two mutations must be analyzed.
Alternatively, the CAF20 protein is known to compete with eIF4G for eIF4E (Altmann et
al., 1997; Ptushkina et al., 1998). Over-expression of CAF20 could therefore be used to
disrupt the eIF4E contact to PAB1.
If it cannot be demonstrated that PUF3 communicates with PAB1 through the
TIFs, it is possible that another protein mediates the connection (Figure 20C). It is
possible that an unknown protein (not a TIF) contacts PUF3 which in turn contacts PAB1
to promote circularization and dissociation from the poly(A) tail. This hypothetical
protein could be identified through PUF3 purification and mass spec analysis of
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associated proteins. An alternative method would be through a two-hybrid screen for
proteins that interact with PUF3. Since this protein would need to contact PAB1, likely
candidates would be proteins that contact PUF3 who are known to also contact PAB1.
This work shows that PAB1 has multiple roles, both in deadenylation and
translation. Two observations suggest it is likely that PAB1 has a larger role on
deadenylation than translation. First, every PAB1 domain, except RRM4, had an effect
on deadenylation, whereas, only RRM1 and RRM2 had an effect on translation. Second,
PAB1 variants did not show a decrease in translation rate comparable to the decrease in
translation associated with a defect in eIF4E or eIF3. These observations support the
hypothesis that PAB1 has a larger role in deadenylation than in translation. In addition
this work shows that the role of PAB1 in deadenylation is both general and specific for
PUF3 controlled mRNA.
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